action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
,,39959,[],CHEMBL750984,The compound was evaluated for antagonist activity against recombinant human P2X purinoceptor 4 (P2X4),F,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cccc(C(=O)Nc2ccc(S(=O)(=O)[O-])c3cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c23)c1)Nc1cccc(C(=O)Nc2ccc(S(=O)(=O)[O-])c3cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c23)c1.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,,CHEMBL1135773,J Med Chem,2002.0,,CHEMBL216504,,CHEMBL1206126,,0,http://www.openphacts.org/units/Nanomolar,252102,>,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,100000.0
,,1075404,[],CHEMBL751124,Inhibition of inward ion current elicited by ATP at human P2X4 receptor (mutant type),F,,,BAO_0000190,BAO_0000019,assay format,Cc1nc(/N=N/c2ccc(S(=O)(=O)O)cc2S(=O)(=O)O)c(COP(=O)(O)O)c(C=O)c1O,,,CHEMBL1134335,J Med Chem,2001.0,,CHEMBL69234,,CHEMBL69234,4.56,0,http://www.openphacts.org/units/Nanomolar,221491,=,1,1,=,,IC50,nM,,27500.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,27.5
,,1610564,[],CHEMBL872178,Inhibitory concentration against human P2X purinoceptor 4 expressed in Xenopus laevis oocytes,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cccc(C(=O)Nc2cc(C(=O)Nc3ccc(S(=O)(=O)[O-])c4cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c34)ccc2F)c1)Nc1cccc(C(=O)Nc2cc(C(=O)Nc3ccc(S(=O)(=O)[O-])c4cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c34)ccc2F)c1.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,,CHEMBL1140384,J Med Chem,2005.0,,CHEMBL413145,,CHEMBL1207514,,0,http://www.openphacts.org/units/Nanomolar,403192,<,1,1,<,,IC50,nM,,1000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,Log IC50,,UO_0000065,,-6.0
,,2271933,[],CHEMBL1017979,Antagonist activity at P2X4 receptor up to 10 uM,F,,,BAO_0000190,BAO_0000019,assay format,COc1cc(C(C)C)c(Oc2cnc(NC(CO)CO)nc2N)cc1I,,,CHEMBL1153300,Bioorg Med Chem Lett,2009.0,,CHEMBL494161,,CHEMBL494161,,1,http://www.openphacts.org/units/Nanomolar,755715,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,2272037,[],CHEMBL960840,Inhibition of P2X4 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(C)C)c(Oc2cnc(N)nc2N)cc1I,,,CHEMBL1153301,Bioorg Med Chem Lett,2009.0,,CHEMBL526307,,CHEMBL526307,,0,http://www.openphacts.org/units/Nanomolar,756109,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,3098212,[],CHEMBL1069596,Antagonist activity at P2X4 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1nc(-c2ccccc2)oc1C(=O)NC(C)CN1CCN(c2ncccn2)CC1,,,CHEMBL1159093,Bioorg Med Chem Lett,2010.0,,CHEMBL605325,,CHEMBL605325,,0,http://www.openphacts.org/units/Nanomolar,884240,<,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,pIC50,,UO_0000065,,5.0
,,3099404,[],CHEMBL1069596,Antagonist activity at P2X4 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CC(=O)N1CCN(C[C@@H](C)NC(=O)c2cc3c(-c4ccccc4)nn(C)c3s2)CC1,,,CHEMBL1159093,Bioorg Med Chem Lett,2010.0,,CHEMBL599760,,CHEMBL599760,,0,http://www.openphacts.org/units/Nanomolar,885303,<,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,pIC50,,UO_0000065,,5.0
,,12148271,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1ccccc1OCCOc1ccccc1NC(=O)c1ccccc1)c1ccccc1,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180157,,CHEMBL2180157,,0,http://www.openphacts.org/units/Nanomolar,1753351,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148272,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OCC(=O)Nc1ccccc1OCCBr,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180156,,CHEMBL2180156,,0,http://www.openphacts.org/units/Nanomolar,1753350,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148273,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(OCc1ccccc1)N1CCOc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180155,,CHEMBL2180155,,0,http://www.openphacts.org/units/Nanomolar,1753349,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148274,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1ccccc1)N1CCOc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180154,,CHEMBL2180154,,0,http://www.openphacts.org/units/Nanomolar,1753348,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148275,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(N1CCOCC1)N1CCOc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180153,,CHEMBL2180153,,0,http://www.openphacts.org/units/Nanomolar,1753347,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148276,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1ccccc1O)OCc1ccccc1,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180152,,CHEMBL2180152,,0,http://www.openphacts.org/units/Nanomolar,1753346,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148277,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OCC(=O)Nc1ccccc1O,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180151,,CHEMBL2180151,5.47,0,http://www.openphacts.org/units/Nanomolar,1753345,=,1,1,=,,IC50,nM,,3390.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,3.39
,,12148278,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1ccccc1O)c1ccccc1,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL229357,,CHEMBL229357,,0,http://www.openphacts.org/units/Nanomolar,1753344,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148279,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1ccccc1O)N1CCOCC1,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180150,,CHEMBL2180150,,0,http://www.openphacts.org/units/Nanomolar,1753343,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148280,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,OC1(c2ccccc2)c2ccccc2N(Cc2ccccc2)c2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180149,,CHEMBL2180149,5.61,0,http://www.openphacts.org/units/Nanomolar,1753342,=,1,1,=,,IC50,nM,,2440.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,2.44
,,12148281,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=c1c2ccccc2n(Cc2ccc([N+](=O)[O-])cc2)c2ccccc12,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180148,,CHEMBL2180148,5.60,0,http://www.openphacts.org/units/Nanomolar,1753341,=,1,1,=,,IC50,nM,,2490.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,2.49
,,12148282,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(Cn2c3ccccc3c(=O)c3ccccc32)cc1,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180147,,CHEMBL2180147,4.93,0,http://www.openphacts.org/units/Nanomolar,1753340,=,1,1,=,,IC50,nM,,11800.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,11.8
,,12148283,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(Cn2c3ccccc3c(=O)c3ccccc32)cc1,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL484675,,CHEMBL484675,4.99,0,http://www.openphacts.org/units/Nanomolar,1753339,=,1,1,=,,IC50,nM,,10300.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.3
,,12148284,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=c1c2ccccc2n(Cc2ccccc2)c2ccccc12,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL451082,,CHEMBL451082,5.22,0,http://www.openphacts.org/units/Nanomolar,1753338,=,1,1,=,,IC50,nM,,5970.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,5.97
,,12148285,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)C(=O)n1c2ccccc2c(=O)c2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180146,,CHEMBL2180146,4.41,0,http://www.openphacts.org/units/Nanomolar,1753337,=,1,1,=,,IC50,nM,,39100.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,39.1
,,12148286,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1ccccc1)n1c2ccccc2c(=O)c2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180145,,CHEMBL2180145,4.57,0,http://www.openphacts.org/units/Nanomolar,1753336,=,1,1,=,,IC50,nM,,26900.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,26.9
,,12148287,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,Clc1c2ccccc2nc2ccccc12,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180144,,CHEMBL2180144,,0,http://www.openphacts.org/units/Nanomolar,1753335,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148288,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(SCCc1ccccc1)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180143,,CHEMBL2180143,,0,http://www.openphacts.org/units/Nanomolar,1753334,>=,1,1,>=,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148289,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(OCCc1ccccc1)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180142,,CHEMBL2180142,5.41,0,http://www.openphacts.org/units/Nanomolar,1753333,=,1,1,=,,IC50,nM,,3930.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,3.93
,,12148290,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(COC(=O)N2c3ccccc3Oc3ccccc32)cc1,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180141,,CHEMBL2180141,5.58,0,http://www.openphacts.org/units/Nanomolar,1753332,=,1,1,=,,IC50,nM,,2640.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,2.64
,,12148291,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(OCc1ccc([N+](=O)[O-])cc1)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180140,,CHEMBL2180140,,0,http://www.openphacts.org/units/Nanomolar,1753331,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148292,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(OCc1ccc(Cl)cc1)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180139,,CHEMBL2180139,5.99,0,http://www.openphacts.org/units/Nanomolar,1753330,=,1,1,=,,IC50,nM,,1020.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,1.02
,,12148293,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(COC(=O)N2c3ccccc3Oc3ccccc32)cc1,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180138,,CHEMBL2180138,5.64,0,http://www.openphacts.org/units/Nanomolar,1753329,=,1,1,=,,IC50,nM,,2280.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,2.28
,,12148294,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(OCc1ccccc1)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180137,,CHEMBL2180137,6.72,1,http://www.openphacts.org/units/Nanomolar,1753328,=,1,1,=,,IC50,nM,,189.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.189
,,12148295,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)OC(=O)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180136,,CHEMBL2180136,5.63,0,http://www.openphacts.org/units/Nanomolar,1753327,=,1,1,=,,IC50,nM,,2350.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,2.35
,,12148296,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180135,,CHEMBL2180135,4.28,0,http://www.openphacts.org/units/Nanomolar,1753326,=,1,1,=,,IC50,nM,,52300.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,52.3
,,12148297,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C(=O)N2c3ccccc3Oc3ccccc32)CC1,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180178,,CHEMBL2180178,,0,http://www.openphacts.org/units/Nanomolar,1753372,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148298,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(N1CCCCC1)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180177,,CHEMBL2180177,4.97,0,http://www.openphacts.org/units/Nanomolar,1753371,=,1,1,=,,IC50,nM,,10700.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.7
,,12148299,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(N1CCOCC1)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180176,,CHEMBL2180176,,0,http://www.openphacts.org/units/Nanomolar,1753370,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148300,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)N(C(=O)N1c2ccccc2Oc2ccccc21)C(C)C,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180175,,CHEMBL2180175,4.91,0,http://www.openphacts.org/units/Nanomolar,1753369,=,1,1,=,,IC50,nM,,12400.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,12.4
,,12148301,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,CCCN(CCC)C(=O)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180174,,CHEMBL2180174,5.57,0,http://www.openphacts.org/units/Nanomolar,1753368,=,1,1,=,,IC50,nM,,2690.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,2.69
,,12148302,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)C(=O)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180173,,CHEMBL2180173,4.76,0,http://www.openphacts.org/units/Nanomolar,1753367,=,1,1,=,,IC50,nM,,17400.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,17.4
,,12148303,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)C(=O)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180172,,CHEMBL2180172,4.61,0,http://www.openphacts.org/units/Nanomolar,1753366,=,1,1,=,,IC50,nM,,24600.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,24.6
,,12148304,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCc1ccccc1)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180171,,CHEMBL2180171,5.75,0,http://www.openphacts.org/units/Nanomolar,1753365,=,1,1,=,,IC50,nM,,1780.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,1.78
,,12148305,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCc1cc(Cl)cc(Cl)c1)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180170,,CHEMBL2180170,,0,http://www.openphacts.org/units/Nanomolar,1753364,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148306,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCc1ccc(Cl)cc1)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180169,,CHEMBL2180169,5.02,0,http://www.openphacts.org/units/Nanomolar,1753363,=,1,1,=,,IC50,nM,,9540.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,9.54
,,12148307,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCc1ccccc1)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180168,,CHEMBL2180168,,0,http://www.openphacts.org/units/Nanomolar,1753362,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148308,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCC(NC(=O)N2c3ccccc3Oc3ccccc32)CC1,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180167,,CHEMBL2180167,4.34,0,http://www.openphacts.org/units/Nanomolar,1753361,=,1,1,=,,IC50,nM,,45800.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,45.8
,,12148309,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)CCCNC(=O)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180166,,CHEMBL2180166,,0,http://www.openphacts.org/units/Nanomolar,1753360,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148310,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC1CCCCC1)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180165,,CHEMBL2180165,,0,http://www.openphacts.org/units/Nanomolar,1753359,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148311,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)NC(=O)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180164,,CHEMBL2180164,,0,http://www.openphacts.org/units/Nanomolar,1753358,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148312,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,CNC(=O)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180163,,CHEMBL2180163,,0,http://www.openphacts.org/units/Nanomolar,1753357,>=,1,1,>=,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148313,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180162,,CHEMBL2180162,,0,http://www.openphacts.org/units/Nanomolar,1753356,>=,1,1,>=,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148314,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(Cc1ccccc1)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180161,,CHEMBL2180161,,0,http://www.openphacts.org/units/Nanomolar,1753355,>=,1,1,>=,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148315,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(S(=O)(=O)N2c3ccccc3Oc3ccccc32)cc1,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180160,,CHEMBL2180160,5.86,0,http://www.openphacts.org/units/Nanomolar,1753354,=,1,1,=,,IC50,nM,,1380.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,1.38
,,12148316,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1ccccc1)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180159,,CHEMBL2180159,,0,http://www.openphacts.org/units/Nanomolar,1753353,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148317,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(C(=O)N2c3ccccc3Oc3ccccc32)cc1,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180158,,CHEMBL2180158,4.97,0,http://www.openphacts.org/units/Nanomolar,1753352,=,1,1,=,,IC50,nM,,10800.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.8
,,12148318,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1ccc(Cl)cc1)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180185,,CHEMBL2180185,5.28,0,http://www.openphacts.org/units/Nanomolar,1753383,=,1,1,=,,IC50,nM,,5290.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,5.29
,,12148319,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1ccc([N+](=O)[O-])cc1)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180184,,CHEMBL2180184,5.37,0,http://www.openphacts.org/units/Nanomolar,1753382,=,1,1,=,,IC50,nM,,4290.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,4.29
,,12148320,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1ccccc1)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180183,,CHEMBL2180183,5.39,0,http://www.openphacts.org/units/Nanomolar,1753381,=,1,1,=,,IC50,nM,,4110.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,4.11
,,12148321,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180182,,CHEMBL2180182,,0,http://www.openphacts.org/units/Nanomolar,1753380,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148322,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cl)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180181,,CHEMBL2180181,4.63,0,http://www.openphacts.org/units/Nanomolar,1753379,=,1,1,=,,IC50,nM,,23200.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,23.2
,,12148323,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(CN2c3ccccc3Oc3ccccc32)cc1,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180180,,CHEMBL2180180,,0,http://www.openphacts.org/units/Nanomolar,1753378,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,12148324,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CN=C(c2cccc(Br)c2)c2oc3ccccc3c2N1,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL2180179,,CHEMBL2180179,6.30,1,http://www.openphacts.org/units/Nanomolar,1753377,=,1,1,=,,IC50,nM,,500.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.5
,,12148325,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1,,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL490,PAROXETINE,CHEMBL490,5.73,1,http://www.openphacts.org/units/Nanomolar,1753376,=,1,1,=,,IC50,nM,,1870.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,1.87
,,12148326,[],CHEMBL2184479,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@H]2OC3(O[C@H]21)C([N+](=O)[O-])=CC(=[N+]([O-])[O-])C=C3[N+](=O)[O-],,,CHEMBL2177033,J Med Chem,2012.0,,CHEMBL1163419,TNP-ATP,CHEMBL1163419,4.82,0,http://www.openphacts.org/units/Nanomolar,1753375,=,1,1,=,,IC50,nM,,15200.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,15.2
,,13885155,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COC1=Cc2ccccc2N(C(N)=O)c2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL3103368,,CHEMBL3103368,,0,http://www.openphacts.org/units/Nanomolar,1958066,>,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13885156,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)N1c2ccccc2C=C(N)c2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL3103367,,CHEMBL3103367,,0,http://www.openphacts.org/units/Nanomolar,1958065,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,13885157,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CNC1=Cc2ccccc2N(C(N)=O)c2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '16.71', 'le': '0.30', 'lle': '1.50', 'sei': '7.60'}",CHEMBL3103366,,CHEMBL3103366,4.43,0,http://www.openphacts.org/units/Nanomolar,1958064,=,1,1,=,,IC50,nM,,36900.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,36.9
,,13885158,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)N1c2ccccc2CC(=O)c2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL1068,OXCARBAZEPINE,CHEMBL1068,,0,http://www.openphacts.org/units/Nanomolar,1958063,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,13885159,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOC1Cc2ccccc2N(C(N)=O)c2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL1359461,,CHEMBL1359461,,0,http://www.openphacts.org/units/Nanomolar,1958062,>,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13885160,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)O[C@H]1Cc2ccccc2N(C(N)=O)c2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL87992,ESLICARBAZEPINE ACETATE,CHEMBL87992,,0,http://www.openphacts.org/units/Nanomolar,1958061,>,1,1,>,,IC50,nM,,20000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,20.0
,,13885161,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)N1c2ccccc2CCc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL41543,,CHEMBL41543,,0,http://www.openphacts.org/units/Nanomolar,1958098,>,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886066,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)N1c2ccccc2CC(O)c2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL1067,LICARBAZEPINE,CHEMBL1067,,0,http://www.openphacts.org/units/Nanomolar,1958097,>,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886067,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)N1c2ccccc2C2OC2c2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL1258,CARBAMAZEPINE EPOXIDE,CHEMBL1258,,0,http://www.openphacts.org/units/Nanomolar,1958096,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,13886068,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)N1c2ccccc2C=Cc2cc(O)ccc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL3103396,,CHEMBL3103396,,0,http://www.openphacts.org/units/Nanomolar,1958095,=,1,1,=,,IC50,nM,,146000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,146.0
,,13886069,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)N1c2ccccc2C=Cc2ccc(O)cc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '16.40', 'le': '0.30', 'lle': '1.05', 'sei': '6.22'}",CHEMBL3103395,,CHEMBL3103395,4.14,0,http://www.openphacts.org/units/Nanomolar,1958094,=,1,1,=,,IC50,nM,,72800.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,72.8
,,13886070,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)C(=O)N1c2ccccc2C=Cc2ccncc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '13.63', 'le': '0.25', 'lle': '-0.17', 'sei': '10.98'}",CHEMBL3103394,,CHEMBL3103394,4.00,0,http://www.openphacts.org/units/Nanomolar,1958093,=,1,1,=,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886071,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)N1c2ccccc2C=Cc2cc(F)ccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL2177626,,CHEMBL2177626,,0,http://www.openphacts.org/units/Nanomolar,1958092,>,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886072,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)c1ccc2c(c1)N(C(N)=O)c1ccccc1C=C2,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '17.24', 'le': '0.31', 'lle': '1.37', 'sei': '9.71'}",CHEMBL3103393,,CHEMBL3103393,4.82,0,http://www.openphacts.org/units/Nanomolar,1958091,=,1,1,=,,IC50,nM,,15300.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,15.3
,,13886073,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)N1c2ccccc2C=Cc2c1ccc1ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '14.98', 'le': '0.27', 'lle': '-0.25', 'sei': '9.26'}",CHEMBL3103392,,CHEMBL3103392,4.29,0,http://www.openphacts.org/units/Nanomolar,1958090,=,1,1,=,,IC50,nM,,51400.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,51.4
,,13886074,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1)N(C(N)=O)c1ccccc1C=C2,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL3103391,,CHEMBL3103391,,0,http://www.openphacts.org/units/Nanomolar,1958089,>,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886075,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)N1c2ccccc2C=Cc2ccc(C(F)(F)F)cc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '14.01', 'le': '0.26', 'lle': '-0.15', 'sei': '9.20'}",CHEMBL3103390,,CHEMBL3103390,4.26,0,http://www.openphacts.org/units/Nanomolar,1958088,=,1,1,=,,IC50,nM,,54600.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,54.6
,,13886076,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)N1c2ccccc2C=Cc2ccc(F)cc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL3103389,,CHEMBL3103389,,0,http://www.openphacts.org/units/Nanomolar,1958087,>,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886077,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc2c(c1)N(C(N)=O)c1ccccc1C=C2,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL3103388,,CHEMBL3103388,,0,http://www.openphacts.org/units/Nanomolar,1958086,>,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886078,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)C(=O)N1c2ccccc2C=Cc2cccc(C(=O)N(C(C)C)C(C)C)c21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '10.20', 'le': '0.19', 'lle': '-1.75', 'sei': '9.76'}",CHEMBL3103387,,CHEMBL3103387,4.28,0,http://www.openphacts.org/units/Nanomolar,1958085,=,1,1,=,,IC50,nM,,52500.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,52.5
,,13886079,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)N(C(=O)c1cccc2c1Nc1ccccc1C=C2)C(C)C,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '14.09', 'le': '0.26', 'lle': '-0.66', 'sei': '13.96'}",CHEMBL3103386,,CHEMBL3103386,4.51,0,http://www.openphacts.org/units/Nanomolar,1958084,=,1,1,=,,IC50,nM,,30600.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,30.6
,,13886080,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)N(C(=O)N1c2ccccc2C=Cc2ccccc21)C(C)C,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '17.05', 'le': '0.31', 'lle': '-0.09', 'sei': '23.20'}",CHEMBL3103385,,CHEMBL3103385,5.46,0,http://www.openphacts.org/units/Nanomolar,1958083,=,1,1,=,,IC50,nM,,3440.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,3.44
,,13886081,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1ccncc1)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL3103384,,CHEMBL3103384,,0,http://www.openphacts.org/units/Nanomolar,1958082,>,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886082,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1ccccc1)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '12.81', 'le': '0.23', 'lle': '-1.54', 'sei': '12.37'}",CHEMBL3103383,,CHEMBL3103383,4.00,0,http://www.openphacts.org/units/Nanomolar,1958081,=,1,1,=,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886083,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC1CCC(NC(=O)N2c3ccccc3C=Cc3ccccc32)CC1,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL3103382,,CHEMBL3103382,,0,http://www.openphacts.org/units/Nanomolar,1958080,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,13886084,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC1CCC(O)CC1)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL3103381,,CHEMBL3103381,,0,http://www.openphacts.org/units/Nanomolar,1958079,>,1,1,>,,IC50,nM,,20000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,20.0
,,13886085,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(N1CCC(O)CC1)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL3103380,,CHEMBL3103380,,0,http://www.openphacts.org/units/Nanomolar,1958078,>,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886086,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(N(CCO)CCO)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL3103379,,CHEMBL3103379,,0,http://www.openphacts.org/units/Nanomolar,1958077,>,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886087,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCC(NC(=O)N2c3ccccc3C=Cc3ccccc32)CC1,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL3103378,,CHEMBL3103378,,0,http://www.openphacts.org/units/Nanomolar,1958076,>=,1,1,>=,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886088,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)NC(=O)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '16.62', 'le': '0.30', 'lle': '0.04', 'sei': '15.03'}",CHEMBL3103377,,CHEMBL3103377,4.86,0,http://www.openphacts.org/units/Nanomolar,1958075,=,1,1,=,,IC50,nM,,13800.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,13.8
,,13886089,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)CCN(C)C(=O)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL3103376,,CHEMBL3103376,,0,http://www.openphacts.org/units/Nanomolar,1958074,>=,1,1,>=,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886090,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN(CCC)C(=O)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '15.94', 'le': '0.29', 'lle': '-0.44', 'sei': '21.69'}",CHEMBL3103375,,CHEMBL3103375,5.11,0,http://www.openphacts.org/units/Nanomolar,1958073,=,1,1,=,,IC50,nM,,7780.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,7.78
,,13886091,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCNC(=O)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL3103374,,CHEMBL3103374,,0,http://www.openphacts.org/units/Nanomolar,1958072,>=,1,1,>=,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886092,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)C(=O)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL3103373,,CHEMBL3103373,,0,http://www.openphacts.org/units/Nanomolar,1958071,>=,1,1,>=,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886093,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(N1CCCC1)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '15.38', 'le': '0.28', 'lle': '-0.05', 'sei': '18.97'}",CHEMBL3103372,,CHEMBL3103372,4.47,0,http://www.openphacts.org/units/Nanomolar,1958070,=,1,1,=,,IC50,nM,,34100.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,34.1
,,13886094,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(N1CCCCC1)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '15.98', 'le': '0.29', 'lle': '-0.05', 'sei': '20.65'}",CHEMBL3103371,,CHEMBL3103371,4.86,0,http://www.openphacts.org/units/Nanomolar,1958069,=,1,1,=,,IC50,nM,,13700.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,13.7
,,13886095,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCc1ccccc1)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '13.05', 'le': '0.23', 'lle': '-0.82', 'sei': '13.73'}",CHEMBL3103370,,CHEMBL3103370,4.44,0,http://www.openphacts.org/units/Nanomolar,1958068,=,1,1,=,,IC50,nM,,36200.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,36.2
,,13886096,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC1CCCCC1)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '14.04', 'le': '0.25', 'lle': '-0.88', 'sei': '13.83'}",CHEMBL3103369,,CHEMBL3103369,4.47,0,http://www.openphacts.org/units/Nanomolar,1958067,=,1,1,=,,IC50,nM,,33800.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,33.8
,,13886097,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(CCNC(=O)N2c3ccccc3C=Cc3ccccc32)cc1,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '12.32', 'le': '0.22', 'lle': '-0.71', 'sei': '10.97'}",CHEMBL3103405,,CHEMBL3103405,4.56,0,http://www.openphacts.org/units/Nanomolar,1958114,=,1,1,=,,IC50,nM,,27400.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,27.4
,,13886098,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)NC(=O)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '16.94', 'le': '0.31', 'lle': '0.29', 'sei': '14.58'}",CHEMBL3103404,,CHEMBL3103404,4.72,0,http://www.openphacts.org/units/Nanomolar,1958113,=,1,1,=,,IC50,nM,,19200.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,19.2
,,13886099,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)CCCNC(=O)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '12.44', 'le': '0.23', 'lle': '0.03', 'sei': '11.24'}",CHEMBL1739848,,CHEMBL1739848,4.00,0,http://www.openphacts.org/units/Nanomolar,1958112,=,1,1,=,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886100,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(N1CCOCC1)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL3103403,,CHEMBL3103403,,0,http://www.openphacts.org/units/Nanomolar,1958111,>=,1,1,>=,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886101,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CNC(=O)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL1594958,,CHEMBL1594958,,0,http://www.openphacts.org/units/Nanomolar,1958110,>=,1,1,>=,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886102,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCc1ccccc1)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '12.57', 'le': '0.22', 'lle': '-1.12', 'sei': '12.69'}",CHEMBL3103402,,CHEMBL3103402,4.10,0,http://www.openphacts.org/units/Nanomolar,1958109,=,1,1,=,,IC50,nM,,78900.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,78.9
,,13886103,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)C(=O)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '16.91', 'le': '0.31', 'lle': '0.17', 'sei': '20.99'}",CHEMBL1483754,,CHEMBL1483754,4.94,0,http://www.openphacts.org/units/Nanomolar,1958108,=,1,1,=,,IC50,nM,,11400.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,11.4
,,13886104,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(OCc1ccccc1)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '15.95', 'le': '0.29', 'lle': '-0.43', 'sei': '17.67'}",CHEMBL3103401,,CHEMBL3103401,5.22,0,http://www.openphacts.org/units/Nanomolar,1958107,=,1,1,=,,IC50,nM,,6020.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,6.02
,,13886105,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)COC(=O)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '13.63', 'le': '0.25', 'lle': '-1.10', 'sei': '13.54'}",CHEMBL3103400,,CHEMBL3103400,4.00,0,http://www.openphacts.org/units/Nanomolar,1958106,=,1,1,=,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886106,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '15.92', 'le': '0.29', 'lle': '-0.07', 'sei': '13.54'}",CHEMBL1716713,,CHEMBL1716713,4.00,0,http://www.openphacts.org/units/Nanomolar,1958105,=,1,1,=,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886107,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,C1=Cc2ccccc2N(Cc2ccccc2)c2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL3103399,,CHEMBL3103399,,0,http://www.openphacts.org/units/Nanomolar,1958104,>,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886108,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1ccccc1)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '15.58', 'le': '0.28', 'lle': '-0.52', 'sei': '22.81'}",CHEMBL3103398,,CHEMBL3103398,4.63,0,http://www.openphacts.org/units/Nanomolar,1958103,=,1,1,=,,IC50,nM,,23300.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,23.3
,,13886109,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL3103397,,CHEMBL3103397,,0,http://www.openphacts.org/units/Nanomolar,1958102,>,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886110,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,,CHEMBL108,CARBAMAZEPINE,CHEMBL108,,0,http://www.openphacts.org/units/Nanomolar,1958101,>,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,13886111,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(OCc1ccccc1)N1c2ccccc2Oc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '21.19', 'le': '0.38', 'lle': '1.45', 'sei': '17.34'}",CHEMBL2180137,,CHEMBL2180137,6.72,0,http://www.openphacts.org/units/Nanomolar,1958100,=,1,1,=,,IC50,nM,,189.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.189
,,13886112,[],CHEMBL3106505,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1,,,CHEMBL3102848,Bioorg Med Chem,2014.0,"{'bei': '16.18', 'le': '0.30', 'lle': '2.00', 'sei': '13.42'}",CHEMBL490,PAROXETINE,CHEMBL490,5.33,0,http://www.openphacts.org/units/Nanomolar,1958099,=,1,1,=,,IC50,nM,,4680.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,4.68
,,16404857,[],CHEMBL3744768,Inhibition of P2X4R (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Cl)c(OCCO)cc1NC(=O)C1=CNC(=O)C[C@H]1c1ccc(F)cc1,,,CHEMBL3739255,J Med Chem,2015.0,,CHEMBL3741992,,CHEMBL3741992,,0,http://www.openphacts.org/units/Nanomolar,2737541,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,18297947,[],CHEMBL4124037,Antagonist activity at P2X4 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)C2=C(O)C(=O)N(c3ccc(-c4ccon4)cc3)C2C2CCCCC2)cc1,,,CHEMBL4118217,Bioorg Med Chem Lett,2018.0,,CHEMBL4127637,,CHEMBL4127637,,0,http://www.openphacts.org/units/Nanomolar,3037572,>,1,1,>,,IC50,nM,,30000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,30.0
,Not Determined,18416698,[],CHEMBL4153218,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced calcium flux measured for 30 secs at 0.4 secs intervals by Flou-4-AM dye based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC1=CCC(C(=O)/N=C2\CC=C(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c32)=C/C1=N/C(=O)C1=CC=C/C(=N\C(=O)/N=C2\C=CC=C(C(=O)/N=C3/CC(C(=O)/N=C4\CC=C(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c54)=CC=C3C)C2)C1,,,CHEMBL4152208,Eur J Med Chem,2018.0,,CHEMBL3040216,,CHEMBL3040216,,0,,3056594,,1,0,,,IC50,,,,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,,,,
,Not Determined,18416699,[],CHEMBL4153218,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced calcium flux measured for 30 secs at 0.4 secs intervals by Flou-4-AM dye based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(=O)Nc2ccc(S(=O)(=O)[O-])cc2)cc(C(=O)Nc2ccc(S(=O)(=O)[O-])cc2)c1)Nc1cc(C(=O)Nc2ccc(S(=O)(=O)[O-])cc2)cc(C(=O)Nc2ccc(S(=O)(=O)[O-])cc2)c1.[Na+].[Na+].[Na+].[Na+],,,CHEMBL4152208,Eur J Med Chem,2018.0,,CHEMBL4160315,,CHEMBL4300424,,0,,3056596,,1,0,,,IC50,,,,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,,,,
,,18416700,[],CHEMBL4153218,Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced calcium flux measured for 30 secs at 0.4 secs intervals by Flou-4-AM dye based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CN=C(c2cccc(Br)c2)c2oc3ccccc3c2N1,,,CHEMBL4152208,Eur J Med Chem,2018.0,"{'bei': '18.18', 'le': '0.40', 'lle': '2.48', 'sei': '11.82'}",CHEMBL2180179,,CHEMBL2180179,6.46,0,http://www.openphacts.org/units/Nanomolar,3056597,=,1,1,=,,IC50,nM,,350.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.35
,,18416706,[],CHEMBL4153224,Antagonist activity at human P2X4 receptor expressed in CHO cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CN=C(c2cccc(Br)c2)c2oc3ccccc3c2N1,,,CHEMBL4152208,Eur J Med Chem,2018.0,"{'bei': '17.74', 'le': '0.39', 'lle': '2.32', 'sei': '11.54'}",CHEMBL2180179,,CHEMBL2180179,6.30,1,http://www.openphacts.org/units/Nanomolar,3056597,=,1,1,=,,IC50,nM,,500.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.5
,,18926143,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1Oc1ccc(-c2nccs2)cc1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '15.05', 'le': '0.31', 'lle': '2.44', 'sei': '6.75'}",CHEMBL4463320,,CHEMBL4463320,7.52,0,http://www.openphacts.org/units/Nanomolar,3157419,=,1,1,=,,IC50,nM,,30.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,30.0
,,18926144,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1Oc1ccc(C2CCOC2)cc1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '14.63', 'le': '0.29', 'lle': '2.66', 'sei': '6.61'}",CHEMBL4561582,,CHEMBL4561582,7.12,0,http://www.openphacts.org/units/Nanomolar,3157420,=,1,1,=,,IC50,nM,,75.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,75.0
,,18926145,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1Oc1cccc(-n2cnnc2)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '14.82', 'le': '0.30', 'lle': '3.63', 'sei': '5.55'}",CHEMBL4438981,,CHEMBL4438981,7.17,0,http://www.openphacts.org/units/Nanomolar,3157421,=,1,1,=,,IC50,nM,,67.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,67.0
,,18926146,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)Nc1cccc(Oc2ccc(NC(=O)Cc3ccccc3Cl)cc2S(N)(=O)=O)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '14.84', 'le': '0.30', 'lle': '3.11', 'sei': '5.51'}",CHEMBL4579675,,CHEMBL4579675,7.03,0,http://www.openphacts.org/units/Nanomolar,3157422,=,1,1,=,,IC50,nM,,93.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,93.0
,,18926147,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1Oc1ccc(N2CCOCC2=O)cc1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '11.19', 'le': '0.23', 'lle': '2.45', 'sei': '4.51'}",CHEMBL4569107,,CHEMBL4569107,5.77,0,http://www.openphacts.org/units/Nanomolar,3157423,=,1,1,=,,IC50,nM,,1681.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,1681.0
,,18926148,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1Oc1cccc(C(=O)N2CCOCC2)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '13.86', 'le': '0.28', 'lle': '3.92', 'sei': '5.74'}",CHEMBL4474747,,CHEMBL4474747,7.35,0,http://www.openphacts.org/units/Nanomolar,3157424,=,1,1,=,,IC50,nM,,45.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,45.0
,,18926149,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1Oc1cccc(N2CCOCC2=O)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '13.16', 'le': '0.26', 'lle': '3.47', 'sei': '5.30'}",CHEMBL4451946,,CHEMBL4451946,6.79,0,http://www.openphacts.org/units/Nanomolar,3157425,=,1,1,=,,IC50,nM,,163.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,163.0
,,18926150,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)c1ccccc1Oc1ccc(NC(=O)Cc2ccccc2Cl)cc1S(N)(=O)=O,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '13.93', 'le': '0.28', 'lle': '2.43', 'sei': '5.57'}",CHEMBL4577125,,CHEMBL4577125,6.62,0,http://www.openphacts.org/units/Nanomolar,3157426,=,1,1,=,,IC50,nM,,242.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,242.0
,,18926151,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)c1cccc(Oc2ccc(NC(=O)Cc3ccccc3Cl)cc2S(N)(=O)=O)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '13.31', 'le': '0.27', 'lle': '2.13', 'sei': '5.33'}",CHEMBL4455317,,CHEMBL4455317,6.32,0,http://www.openphacts.org/units/Nanomolar,3157427,=,1,1,=,,IC50,nM,,474.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,474.0
,,18926152,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)c1ccc(Oc2ccc(NC(=O)Cc3ccccc3Cl)cc2S(N)(=O)=O)cc1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '13.53', 'le': '0.27', 'lle': '2.23', 'sei': '5.41'}",CHEMBL4539332,,CHEMBL4539332,6.42,0,http://www.openphacts.org/units/Nanomolar,3157428,=,1,1,=,,IC50,nM,,376.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,376.0
,,18926153,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1Oc1ccccn1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '15.21', 'le': '0.31', 'lle': '3.00', 'sei': '5.71'}",CHEMBL4533763,,CHEMBL4533763,6.36,0,http://www.openphacts.org/units/Nanomolar,3157429,=,1,1,=,,IC50,nM,,441.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,441.0
,,18926154,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1Oc1cccnc1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '16.07', 'le': '0.33', 'lle': '3.35', 'sei': '6.03'}",CHEMBL4541425,,CHEMBL4541425,6.71,0,http://www.openphacts.org/units/Nanomolar,3157430,=,1,1,=,,IC50,nM,,193.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,193.0
,,18926155,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1Oc1cncc(Cl)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '16.73', 'le': '0.36', 'lle': '3.56', 'sei': '6.80'}",CHEMBL4535761,,CHEMBL4535761,7.57,0,http://www.openphacts.org/units/Nanomolar,3157431,=,1,1,=,,IC50,nM,,27.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,27.0
,,18926156,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1Oc1cnc(Cl)nc1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '12.35', 'le': '0.26', 'lle': '2.20', 'sei': '4.50'}",CHEMBL4455389,,CHEMBL4455389,5.60,0,http://www.openphacts.org/units/Nanomolar,3157432,=,1,1,=,,IC50,nM,,2528.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,2528.0
,,18926157,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(Oc2ccc(NC(=O)Cc3ccccc3Cl)cc2S(N)(=O)=O)cn1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '16.00', 'le': '0.33', 'lle': '4.04', 'sei': '5.79'}",CHEMBL4462109,,CHEMBL4462109,6.73,0,http://www.openphacts.org/units/Nanomolar,3157433,=,1,1,=,,IC50,nM,,185.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,185.0
,,18926158,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1OC1CCCCC1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '17.52', 'le': '0.36', 'lle': '3.53', 'sei': '7.52'}",CHEMBL4539658,,CHEMBL4539658,7.41,0,http://www.openphacts.org/units/Nanomolar,3157434,=,1,1,=,,IC50,nM,,39.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,39.0
,,18926159,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1OCc1ccccc1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '20.19', 'le': '0.41', 'lle': '4.95', 'sei': '8.83'}",CHEMBL4471140,,CHEMBL4471140,8.70,0,http://www.openphacts.org/units/Nanomolar,3157435,=,1,1,=,,IC50,nM,,2.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,2.0
,,18926160,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1OCc1ccccn1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '17.56', 'le': '0.36', 'lle': '4.45', 'sei': '6.81'}",CHEMBL4439570,,CHEMBL4439570,7.58,0,http://www.openphacts.org/units/Nanomolar,3157436,=,1,1,=,,IC50,nM,,26.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,26.0
,,18926161,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1OCCc1ccccc1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '17.35', 'le': '0.35', 'lle': '3.93', 'sei': '7.84'}",CHEMBL4563994,,CHEMBL4563994,7.72,0,http://www.openphacts.org/units/Nanomolar,3157451,=,1,1,=,,IC50,nM,,19.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,19.0
,,18926162,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1OCC1CCC1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '20.30', 'le': '0.42', 'lle': '4.95', 'sei': '8.43'}",CHEMBL4589444,,CHEMBL4589444,8.30,0,http://www.openphacts.org/units/Nanomolar,3157452,=,1,1,=,,IC50,nM,,5.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,5.0
,,18926163,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1OCC1CCO1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '14.86', 'le': '0.31', 'lle': '3.77', 'sei': '5.67'}",CHEMBL4456686,,CHEMBL4456686,6.11,0,http://www.openphacts.org/units/Nanomolar,3157453,=,1,1,=,,IC50,nM,,784.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,784.0
,,18926164,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1OCC1COCCO1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '14.94', 'le': '0.31', 'lle': '4.63', 'sei': '5.63'}",CHEMBL4450002,,CHEMBL4450002,6.59,0,http://www.openphacts.org/units/Nanomolar,3157454,=,1,1,=,,IC50,nM,,258.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,258.0
,,18926165,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1OCC1CCOCC1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '15.62', 'le': '0.32', 'lle': '3.89', 'sei': '6.37'}",CHEMBL4442297,,CHEMBL4442297,6.86,0,http://www.openphacts.org/units/Nanomolar,3157455,=,1,1,=,,IC50,nM,,139.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,139.0
,,18926166,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2C(F)(F)F)ccc1OCC1CCOCC1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '14.93', 'le': '0.30', 'lle': '3.72', 'sei': '6.55'}",CHEMBL4519162,,CHEMBL4519162,7.06,0,http://www.openphacts.org/units/Nanomolar,3157456,=,1,1,=,,IC50,nM,,88.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,88.0
,,18926167,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2C(F)F)ccc1OCC1CCOCC1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '15.30', 'le': '0.31', 'lle': '3.69', 'sei': '6.46'}",CHEMBL4469574,,CHEMBL4469574,6.96,0,http://www.openphacts.org/units/Nanomolar,3157457,=,1,1,=,,IC50,nM,,111.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,111.0
,,18926168,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2F)ccc1OCC1CCOCC1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '14.73', 'le': '0.29', 'lle': '3.76', 'sei': '5.78'}",CHEMBL4458990,,CHEMBL4458990,6.22,0,http://www.openphacts.org/units/Nanomolar,3157458,=,1,1,=,,IC50,nM,,597.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,597.0
,,18926169,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2cccc(F)c2Cl)ccc1OCC1CCOCC1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '16.26', 'le': '0.34', 'lle': '4.32', 'sei': '6.90'}",CHEMBL4517831,,CHEMBL4517831,7.43,0,http://www.openphacts.org/units/Nanomolar,3157459,=,1,1,=,,IC50,nM,,37.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,37.0
,,18926170,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccc(F)cc2Cl)ccc1OCC1CCOCC1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '14.80', 'le': '0.31', 'lle': '3.65', 'sei': '6.28'}",CHEMBL4443857,,CHEMBL4443857,6.76,0,http://www.openphacts.org/units/Nanomolar,3157460,=,1,1,=,,IC50,nM,,173.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,173.0
,,18926171,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2cc(F)ccc2Cl)ccc1OCC1CCOCC1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '15.49', 'le': '0.32', 'lle': '3.97', 'sei': '6.57'}",CHEMBL4452251,,CHEMBL4452251,7.08,0,http://www.openphacts.org/units/Nanomolar,3157461,=,1,1,=,,IC50,nM,,84.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,84.0
,,18926172,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2c(F)cccc2Cl)ccc1OCC1CCOCC1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '17.26', 'le': '0.36', 'lle': '4.78', 'sei': '7.32'}",CHEMBL4555657,,CHEMBL4555657,7.89,0,http://www.openphacts.org/units/Nanomolar,3157462,=,1,1,=,,IC50,nM,,13.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,13.0
,,18926181,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '16.01', 'le': '0.33', 'lle': '2.72', 'sei': '6.78'}",CHEMBL4521594,BAY-1797,CHEMBL4521594,6.68,1,http://www.openphacts.org/units/Nanomolar,3157437,=,1,1,=,,IC50,nM,,211.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,211.0
,,18926182,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cccc(Oc2ccc(NC(=O)Cc3ccccc3Cl)cc2S(N)(=O)=O)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '18.12', 'le': '0.37', 'lle': '4.13', 'sei': '7.52'}",CHEMBL4579583,,CHEMBL4579583,8.10,0,http://www.openphacts.org/units/Nanomolar,3157418,=,1,1,=,,IC50,nM,,8.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,8.0
,,18926183,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1ccccc1Cl,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '14.16', 'le': '0.29', 'lle': '1.94', 'sei': '5.99'}",CHEMBL4470126,,CHEMBL4470126,5.90,0,http://www.openphacts.org/units/Nanomolar,3157417,=,1,1,=,,IC50,nM,,1250.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,1250.0
,,18926184,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1Oc1ccccc1Cl,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '17.47', 'le': '0.37', 'lle': '3.28', 'sei': '8.01'}",CHEMBL4516176,,CHEMBL4516176,7.89,0,http://www.openphacts.org/units/Nanomolar,3157416,=,1,1,=,,IC50,nM,,13.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,13.0
,,18926185,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1Oc1ccccc1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '19.19', 'le': '0.39', 'lle': '4.04', 'sei': '8.12'}",CHEMBL4556573,,CHEMBL4556573,8.00,0,http://www.openphacts.org/units/Nanomolar,3157415,=,1,1,=,,IC50,nM,,10.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,10.0
,,18926186,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccc(C(F)(F)F)cc2)ccc1Oc1cccc(Cl)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '11.89', 'le': '0.25', 'lle': '0.78', 'sei': '5.85'}",CHEMBL4570116,,CHEMBL4570116,5.76,0,http://www.openphacts.org/units/Nanomolar,3157414,=,1,1,=,,IC50,nM,,1718.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,1718.0
,,18926187,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccc(Cl)cc2)ccc1Oc1cccc(Cl)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '14.32', 'le': '0.30', 'lle': '1.85', 'sei': '6.56'}",CHEMBL4444721,,CHEMBL4444721,6.46,0,http://www.openphacts.org/units/Nanomolar,3157413,=,1,1,=,,IC50,nM,,345.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,345.0
,,18926188,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccc(F)cc2)ccc1Oc1cccc(Cl)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '15.11', 'le': '0.31', 'lle': '2.47', 'sei': '6.67'}",CHEMBL4450779,,CHEMBL4450779,6.57,0,http://www.openphacts.org/units/Nanomolar,3157450,=,1,1,=,,IC50,nM,,269.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,269.0
,,18926189,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1,,,CHEMBL4321858,J Med Chem,2019.0,,CHEMBL4516843,BAY-207,CHEMBL4516843,,0,http://www.openphacts.org/units/Nanomolar,3157449,>,1,1,>,,IC50,nM,,25000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,25000.0
,,18926190,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C(=O)Nc1ccc(Oc2cccc(Cl)c2)c(S(N)(=O)=O)c1)c1ccccc1Cl,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '14.77', 'le': '0.31', 'lle': '1.69', 'sei': '6.98'}",CHEMBL4593104,,CHEMBL4593104,6.87,0,http://www.openphacts.org/units/Nanomolar,3157448,=,1,1,=,,IC50,nM,,134.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,134.0
,,18926191,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C(=O)Nc1ccc(Oc2cccc(Cl)c2)c(S(N)(=O)=O)c1)c1ccccc1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '13.71', 'le': '0.28', 'lle': '1.39', 'sei': '6.00'}",CHEMBL4470995,,CHEMBL4470995,5.91,0,http://www.openphacts.org/units/Nanomolar,3157447,=,1,1,=,,IC50,nM,,1242.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,1242.0
,,18926192,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2c(Cl)cccc2Cl)ccc1Oc1cccc(Cl)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '16.11', 'le': '0.36', 'lle': '2.55', 'sei': '7.94'}",CHEMBL4521017,,CHEMBL4521017,7.82,0,http://www.openphacts.org/units/Nanomolar,3157446,=,1,1,=,,IC50,nM,,15.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,15.0
,,18926193,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2c(F)cccc2Cl)ccc1Oc1cccc(Cl)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '17.14', 'le': '0.37', 'lle': '3.30', 'sei': '8.17'}",CHEMBL4447043,,CHEMBL4447043,8.05,0,http://www.openphacts.org/units/Nanomolar,3157445,=,1,1,=,,IC50,nM,,9.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,9.0
,,18926194,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1CC(=O)Nc1ccc(Oc2cccc(Cl)c2)c(S(N)(=O)=O)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '19.46', 'le': '0.40', 'lle': '4.73', 'sei': '8.08'}",CHEMBL4452312,,CHEMBL4452312,8.70,0,http://www.openphacts.org/units/Nanomolar,3157444,=,1,1,=,,IC50,nM,,2.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,2.0
,,18926195,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2C(F)(F)F)ccc1Oc1cccc(Cl)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '15.71', 'le': '0.33', 'lle': '2.64', 'sei': '7.74'}",CHEMBL4438327,,CHEMBL4438327,7.62,0,http://www.openphacts.org/units/Nanomolar,3157443,=,1,1,=,,IC50,nM,,24.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,24.0
,,18926196,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1Oc1cccc(Cl)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '15.59', 'le': '0.33', 'lle': '2.43', 'sei': '7.14'}",CHEMBL4449416,,CHEMBL4449416,7.04,0,http://www.openphacts.org/units/Nanomolar,3157442,=,1,1,=,,IC50,nM,,92.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,92.0
,,18926197,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2F)ccc1Oc1cccc(Cl)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '16.37', 'le': '0.34', 'lle': '3.02', 'sei': '7.23'}",CHEMBL4516450,,CHEMBL4516450,7.12,0,http://www.openphacts.org/units/Nanomolar,3157441,=,1,1,=,,IC50,nM,,76.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,76.0
,,18926198,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(CC(=O)Nc2ccc(Oc3cccc(Cl)c3)c(S(N)(=O)=O)c2)cc1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '15.08', 'le': '0.31', 'lle': '2.23', 'sei': '6.60'}",CHEMBL4451276,,CHEMBL4451276,6.50,0,http://www.openphacts.org/units/Nanomolar,3157440,=,1,1,=,,IC50,nM,,317.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,317.0
,,18926199,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(CC(=O)Nc2ccc(Oc3cccc(Cl)c3)c(S(N)(=O)=O)c2)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '16.90', 'le': '0.34', 'lle': '3.01', 'sei': '7.40'}",CHEMBL4443234,,CHEMBL4443234,7.28,0,http://www.openphacts.org/units/Nanomolar,3157439,=,1,1,=,,IC50,nM,,52.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,52.0
,,18926200,[],CHEMBL4324752,Antagonist activity at human P2X4 receptor tranfected in HEK293 cells assessed as inhibition of Bz-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1CC(=O)Nc1ccc(Oc2cccc(Cl)c2)c(S(N)(=O)=O)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '18.57', 'le': '0.38', 'lle': '3.73', 'sei': '8.12'}",CHEMBL4522504,,CHEMBL4522504,8.00,0,http://www.openphacts.org/units/Nanomolar,3157438,=,1,1,=,,IC50,nM,,10.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,10.0
,,18926322,[],CHEMBL4324779,Antagonist activity at human P2X4 receptor tranfected in human 1321N1 cells assessed as inhibition of Mg-ATP-induced calcium influx incubated for 30 mins and measured every 2 secs for 120 secs by Fluo8-AM staining based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '16.71', 'le': '0.34', 'lle': '3.01', 'sei': '7.07'}",CHEMBL4521594,BAY-1797,CHEMBL4521594,6.97,0,http://www.openphacts.org/units/Nanomolar,3157437,=,1,1,=,,IC50,nM,,108.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,108.0
,,18926326,[],CHEMBL4324782,Antagonist activity at human P2X4 receptor tranfected in human 1321N1 cells assessed as inhibition of inhibition of ATP-evoked current at -90 mV holding potential by Qpatch method,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '15.58', 'le': '0.32', 'lle': '2.53', 'sei': '6.59'}",CHEMBL4521594,BAY-1797,CHEMBL4521594,6.50,0,http://www.openphacts.org/units/Nanomolar,3157437,=,1,1,=,,IC50,nM,,320.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,320.0
,,18926350,[],CHEMBL4324804,Antagonist activity at human P2X4 receptor expressed in CHO cells assessed as reduction in ATP induced calcium influx,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CN=C(c2cccc(Br)c2)c2oc3ccccc3c2N1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '17.74', 'le': '0.39', 'lle': '2.32', 'sei': '11.54'}",CHEMBL2180179,,CHEMBL2180179,6.30,0,http://www.openphacts.org/units/Nanomolar,3157463,=,1,1,=,,IC50,nM,,500.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,500.0
,,18926351,[],CHEMBL4324805,Antagonist activity at human P2X4 receptor expressed in HEK cells assessed as reduction in ATP induced calcium influx,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CN=C(c2cccc(Br)c2)c2oc3ccccc3c2N1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '15.29', 'le': '0.34', 'lle': '1.45', 'sei': '9.95'}",CHEMBL2180179,,CHEMBL2180179,5.43,0,http://www.openphacts.org/units/Nanomolar,3157463,=,1,1,=,,IC50,nM,,3710.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,3710.0
,,18926352,[],CHEMBL4324805,Antagonist activity at human P2X4 receptor expressed in HEK cells assessed as reduction in ATP induced calcium influx,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CC(=O)N(c2ccc(NS(=O)(=O)Cc3ccccc3Cl)cc2)c2ccc3ccccc3c2N1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '14.36', 'le': '0.28', 'lle': '1.83', 'sei': '7.60'}",CHEMBL4557633,,CHEMBL4557633,7.27,0,http://www.openphacts.org/units/Nanomolar,3157466,=,1,1,=,,IC50,nM,,54.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,54.0
,,18926353,[],CHEMBL4324805,Antagonist activity at human P2X4 receptor expressed in HEK cells assessed as reduction in ATP induced calcium influx,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1c(-c2cccc(-c3nnn[nH]3)c2)c2[nH]c3ccccc3c2[nH]c1=O,,,CHEMBL4321858,J Med Chem,2019.0,,CHEMBL4513970,,CHEMBL4513970,,0,http://www.openphacts.org/units/Nanomolar,3157469,<,1,1,<,,IC50,nM,,100.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,100.0
,,18926354,[],CHEMBL4324806,Antagonist activity at human P2X4 receptor expressed in HEK cells by Qpatch method,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CN=C(c2cccc(Br)c2)c2oc3ccccc3c2N1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '15.20', 'le': '0.34', 'lle': '1.42', 'sei': '9.89'}",CHEMBL2180179,,CHEMBL2180179,5.40,0,http://www.openphacts.org/units/Nanomolar,3157463,=,1,1,=,,IC50,nM,,3990.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,3990.0
,,18926355,[],CHEMBL4324807,Antagonist activity at human P2X4 receptor tranfected in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx incubated for 10 mins by Fluo2-AM staining based inverted fluorescence microscopic method,B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '17.39', 'le': '0.33', 'lle': '2.40', 'sei': '14.42'}",CHEMBL490,PAROXETINE,CHEMBL490,5.73,0,http://www.openphacts.org/units/Nanomolar,3157464,=,1,1,=,,IC50,nM,,1870.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,1.87
,,18926357,[],CHEMBL4324809,Antagonist activity at human P2X4 receptor tranfected in human HEK293 cells assessed as inhibition of ATP-induced calcium influx by Fluo2-AM staining based inverted fluorescence microscopic method,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1cc(Br)c(NC(=O)Nc2cccnc2)c(Br)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '14.79', 'le': '0.40', 'lle': '0.74', 'sei': '11.31'}",CHEMBL1532400,,CHEMBL1532400,6.11,0,http://www.openphacts.org/units/Nanomolar,3157465,=,1,1,=,,IC50,nM,,780.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,780.0
,,18926358,[],CHEMBL4324810,Antagonist activity at human P2X4 receptor tranfected in human HEK293 cells at -60 mv holding potential by Whole cell patch-clamp method,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1cc(Br)c(NC(=O)Nc2cccnc2)c(Br)c1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '15.25', 'le': '0.41', 'lle': '0.93', 'sei': '11.66'}",CHEMBL1532400,,CHEMBL1532400,6.30,0,http://www.openphacts.org/units/Nanomolar,3157465,=,1,1,=,,IC50,nM,,500.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,500.0
,,18926359,[],CHEMBL4324811,Antagonist activity at human P2X4 receptor tranfected in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx incubated for 15 mins by Fluo2-AM staining based method,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CC(=O)N(c2ccc(NS(=O)(=O)Cc3ccccc3Cl)cc2)c2ccc3ccccc3c2N1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '14.22', 'le': '0.28', 'lle': '1.75', 'sei': '7.53'}",CHEMBL4557633,,CHEMBL4557633,7.19,0,http://www.openphacts.org/units/Nanomolar,3157466,=,1,1,=,,IC50,nM,,64.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,64.0
,,18926360,[],CHEMBL4324811,Antagonist activity at human P2X4 receptor tranfected in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx incubated for 15 mins by Fluo2-AM staining based method,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cc1ccccc1I)Nc1ccc(N2C(=O)CC(=O)Nc3c2ccc2ccccc32)cc1,,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '11.34', 'le': '0.26', 'lle': '0.74', 'sei': '8.11'}",CHEMBL4464823,,CHEMBL4464823,6.37,0,http://www.openphacts.org/units/Nanomolar,3157467,=,1,1,=,,IC50,nM,,430.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,430.0
,,18926361,[],CHEMBL4324811,Antagonist activity at human P2X4 receptor tranfected in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx incubated for 15 mins by Fluo2-AM staining based method,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CC(=O)N(c2cccc(-c3noc(=S)[n-]3)c2)c2ccc3ccccc3c2N1.[Na+],,,CHEMBL4321858,J Med Chem,2019.0,"{'bei': '16.36', 'le': '0.31', 'lle': '2.03', 'sei': '7.22'}",CHEMBL4462656,,CHEMBL4596410,6.58,0,http://www.openphacts.org/units/Nanomolar,3157468,=,1,1,=,,IC50,nM,,260.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,260.0
,,19309431,[],CHEMBL4415955,Antagonist activity at human P2X4R transfected in 1321N1 cells assessed as inhibition of ATP-mediated calcium influx measured after 10 mins by Fura-2AM assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1cc(Br)c(NC(=O)Nc2cccnc2)c(Br)c1,,,CHEMBL4414589,J Nat Prod,2019.0,"{'bei': '15.15', 'le': '0.41', 'lle': '0.89', 'sei': '11.59'}",CHEMBL1532400,,CHEMBL1532400,6.26,0,http://www.openphacts.org/units/Nanomolar,3224342,=,1,1,=,,IC50,nM,,550.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.55
,,19309432,[],CHEMBL4415955,Antagonist activity at human P2X4R transfected in 1321N1 cells assessed as inhibition of ATP-mediated calcium influx measured after 10 mins by Fura-2AM assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(S(=O)(=O)N2c3ccccc3Oc3ccccc32)cc1,,,CHEMBL4414589,J Nat Prod,2019.0,"{'bei': '18.90', 'le': '0.36', 'lle': '1.75', 'sei': '13.68'}",CHEMBL2180160,,CHEMBL2180160,6.38,0,http://www.openphacts.org/units/Nanomolar,3224343,=,1,1,=,,IC50,nM,,420.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.42
,Not Active,19309433,[],CHEMBL4415955,Antagonist activity at human P2X4R transfected in 1321N1 cells assessed as inhibition of ATP-mediated calcium influx measured after 10 mins by Fura-2AM assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CC12CC3CC(CC(C3)C1)C2)Nc1cccc2nc(NCCNCCO)ccc12,,,CHEMBL4414589,J Nat Prod,2019.0,,CHEMBL562308,,CHEMBL562308,,0,,3224344,,1,0,,,IC50,,,,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,,,,
,,19309434,[],CHEMBL4415955,Antagonist activity at human P2X4R transfected in 1321N1 cells assessed as inhibition of ATP-mediated calcium influx measured after 10 mins by Fura-2AM assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CN=C(c2cccc(Br)c2)c2oc3ccccc3c2N1,,,CHEMBL4414589,J Nat Prod,2019.0,"{'bei': '14.76', 'le': '0.33', 'lle': '1.26', 'sei': '9.60'}",CHEMBL2180179,,CHEMBL2180179,5.24,0,http://www.openphacts.org/units/Nanomolar,3224345,=,1,1,=,,IC50,nM,,5700.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,5.7
,,19309435,[],CHEMBL4415956,Antagonist activity at human P2X4R transfected in HEK293 cells assessed as inhibition of ATP-mediated calcium influx measured after 10 mins by YOPRO-1 dye uptake assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1cc(Br)c(NC(=O)Nc2cccnc2)c(Br)c1,,,CHEMBL4414589,J Nat Prod,2019.0,"{'bei': '14.25', 'le': '0.38', 'lle': '0.52', 'sei': '10.90'}",CHEMBL1532400,,CHEMBL1532400,5.89,0,http://www.openphacts.org/units/Nanomolar,3224342,=,1,1,=,,IC50,nM,,1300.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,1.3
,,19309436,[],CHEMBL4415956,Antagonist activity at human P2X4R transfected in HEK293 cells assessed as inhibition of ATP-mediated calcium influx measured after 10 mins by YOPRO-1 dye uptake assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(S(=O)(=O)N2c3ccccc3Oc3ccccc32)cc1,,,CHEMBL4414589,J Nat Prod,2019.0,"{'bei': '18.14', 'le': '0.35', 'lle': '1.49', 'sei': '13.13'}",CHEMBL2180160,,CHEMBL2180160,6.12,0,http://www.openphacts.org/units/Nanomolar,3224343,=,1,1,=,,IC50,nM,,760.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.76
,Not Active,19309437,[],CHEMBL4415956,Antagonist activity at human P2X4R transfected in HEK293 cells assessed as inhibition of ATP-mediated calcium influx measured after 10 mins by YOPRO-1 dye uptake assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CC12CC3CC(CC(C3)C1)C2)Nc1cccc2nc(NCCNCCO)ccc12,,,CHEMBL4414589,J Nat Prod,2019.0,,CHEMBL562308,,CHEMBL562308,,0,,3224344,,1,0,,,IC50,,,,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,,,,
,,19309438,[],CHEMBL4415956,Antagonist activity at human P2X4R transfected in HEK293 cells assessed as inhibition of ATP-mediated calcium influx measured after 10 mins by YOPRO-1 dye uptake assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CN=C(c2cccc(Br)c2)c2oc3ccccc3c2N1,,,CHEMBL4414589,J Nat Prod,2019.0,"{'bei': '14.18', 'le': '0.31', 'lle': '1.06', 'sei': '9.22'}",CHEMBL2180179,,CHEMBL2180179,5.04,0,http://www.openphacts.org/units/Nanomolar,3224345,=,1,1,=,,IC50,nM,,9200.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,9.2
,,19309443,[],CHEMBL4415959,Antagonist activity at human P2X4R transfected in HEK293 cells assessed as inhibition of ATP-evoked current by patch clamp assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1cc(Br)c(NC(=O)Nc2cccnc2)c(Br)c1,,,CHEMBL4414589,J Nat Prod,2019.0,"{'bei': '15.17', 'le': '0.41', 'lle': '0.90', 'sei': '11.60'}",CHEMBL1532400,,CHEMBL1532400,6.27,0,http://www.openphacts.org/units/Nanomolar,3224342,=,1,1,=,,IC50,nM,,540.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.54
,,19309444,[],CHEMBL4415960,Antagonist activity at human P2X4R transfected in 1321N1 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1cc(Br)c(NC(=O)Nc2cccnc2)c(Br)c1,,,CHEMBL4414589,J Nat Prod,2019.0,"{'bei': '14.03', 'le': '0.38', 'lle': '0.43', 'sei': '10.73'}",CHEMBL1532400,,CHEMBL1532400,5.80,0,http://www.openphacts.org/units/Nanomolar,3224342,=,1,1,=,,IC50,nM,,1600.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,1.6
,,19309445,[],CHEMBL4415960,Antagonist activity at human P2X4R transfected in 1321N1 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(S(=O)(=O)N2c3ccccc3Oc3ccccc32)cc1,,,CHEMBL4414589,J Nat Prod,2019.0,"{'bei': '16.25', 'le': '0.31', 'lle': '0.85', 'sei': '11.76'}",CHEMBL2180160,,CHEMBL2180160,5.48,0,http://www.openphacts.org/units/Nanomolar,3224343,=,1,1,=,,IC50,nM,,3300.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,3.3
,Not Active,19309446,[],CHEMBL4415960,Antagonist activity at human P2X4R transfected in 1321N1 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CN=C(c2cccc(Br)c2)c2oc3ccccc3c2N1,,,CHEMBL4414589,J Nat Prod,2019.0,,CHEMBL2180179,,CHEMBL2180179,,0,,3224345,,1,0,,,IC50,,,,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,,,,
,,19309447,[],CHEMBL4415961,Antagonist activity at human P2X4R transfected in HEK293 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(S(=O)(=O)N2c3ccccc3Oc3ccccc32)cc1,,,CHEMBL4414589,J Nat Prod,2019.0,"{'bei': '17.35', 'le': '0.33', 'lle': '1.22', 'sei': '12.56'}",CHEMBL2180160,,CHEMBL2180160,5.85,0,http://www.openphacts.org/units/Nanomolar,3224343,=,1,1,=,,IC50,nM,,1400.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,1.4
,,19309448,[],CHEMBL4415961,Antagonist activity at human P2X4R transfected in HEK293 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CN=C(c2cccc(Br)c2)c2oc3ccccc3c2N1,,,CHEMBL4414589,J Nat Prod,2019.0,"{'bei': '16.67', 'le': '0.37', 'lle': '1.94', 'sei': '10.84'}",CHEMBL2180179,,CHEMBL2180179,5.92,0,http://www.openphacts.org/units/Nanomolar,3224345,=,1,1,=,,IC50,nM,,1200.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,1.2
,,19450886,[],CHEMBL4433710,Antagonist activity at human P2X4R transfected in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx,B,,,BAO_0000190,BAO_0000219,cell-based format,N.N.N.N.Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@H]2OC3(CCCCC3)O[C@H]21,,,CHEMBL4433213,ACS Med Chem Lett,2019.0,"{'bei': '7.71', 'le': '0.17', 'lle': '3.44', 'sei': '1.76'}",CHEMBL4525343,,CHEMBL4597064,4.53,0,http://www.openphacts.org/units/Nanomolar,3249783,=,1,1,=,,IC50,nM,,29600.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,29.6
,,19450887,[],CHEMBL4433710,Antagonist activity at human P2X4R transfected in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx,B,,,BAO_0000190,BAO_0000219,cell-based format,N.N.N.N.Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@H]2O[C@@H](c3ccccc3)O[C@H]21,,,CHEMBL4433213,ACS Med Chem Lett,2019.0,"{'bei': '8.33', 'le': '0.18', 'lle': '3.83', 'sei': '1.93'}",CHEMBL4463334,,CHEMBL4596712,4.96,0,http://www.openphacts.org/units/Nanomolar,3249784,=,1,1,=,,IC50,nM,,11000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,11.0
,,19450888,[],CHEMBL4433710,Antagonist activity at human P2X4R transfected in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx,B,,,BAO_0000190,BAO_0000219,cell-based format,N.N.N.N.Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@H]2O[C@H](c3ccccc3)O[C@H]21,,,CHEMBL4433213,ACS Med Chem Lett,2019.0,"{'bei': '8.24', 'le': '0.18', 'lle': '3.78', 'sei': '1.91'}",CHEMBL4456926,,CHEMBL4594715,4.91,0,http://www.openphacts.org/units/Nanomolar,3249785,=,1,1,=,,IC50,nM,,12400.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,12.4
,,19450889,[],CHEMBL4433710,Antagonist activity at human P2X4R transfected in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx,B,,,BAO_0000190,BAO_0000219,cell-based format,N.N.N.N.Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@H]2OCO[C@H]21,,,CHEMBL4433213,ACS Med Chem Lett,2019.0,,CHEMBL4561510,,CHEMBL4598278,,0,http://www.openphacts.org/units/Nanomolar,3249786,>,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,19450890,[],CHEMBL4433710,Antagonist activity at human P2X4R transfected in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx,B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(C)O[C@@H]2[C@H](O1)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O[C@H]2n1cnc2c(N)ncnc21.N.N.N.N,,,CHEMBL4433213,ACS Med Chem Lett,2019.0,"{'bei': '7.89', 'le': '0.17', 'lle': '4.15', 'sei': '1.68'}",CHEMBL4462568,,CHEMBL4596830,4.32,0,http://www.openphacts.org/units/Nanomolar,3249787,=,1,1,=,,IC50,nM,,48000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,48.0
,,19450891,[],CHEMBL4433710,Antagonist activity at human P2X4R transfected in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx,B,,,BAO_0000190,BAO_0000219,cell-based format,N.N.N.N.Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)CP(=O)(O)OP(=O)(O)O)[C@H]2OC3(CCCCC3)O[C@H]21,,,CHEMBL4433213,ACS Med Chem Lett,2019.0,,CHEMBL4463578,,CHEMBL4597901,,0,http://www.openphacts.org/units/Nanomolar,3249788,>,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,,19450892,[],CHEMBL4433710,Antagonist activity at human P2X4R transfected in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx,B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(C)O[C@@H]2[C@H](O1)[C@@H](COC(=O)c1cc(C(=O)O)c(C(=O)O)cc1C(=O)O)O[C@H]2n1cnc2c(N)ncnc21,,,CHEMBL4433213,ACS Med Chem Lett,2019.0,,CHEMBL4570607,,CHEMBL4570607,,0,http://www.openphacts.org/units/Nanomolar,3249789,>,1,1,>,,IC50,nM,,30000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,30.0
,,19450893,[],CHEMBL4433710,Antagonist activity at human P2X4R transfected in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx,B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(C)O[C@@H]2[C@H](O1)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)O[C@H]2n1cnc2c(N)ncnc21,,,CHEMBL4433213,ACS Med Chem Lett,2019.0,,CHEMBL4440260,,CHEMBL4440260,,0,http://www.openphacts.org/units/Nanomolar,3249790,>,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,100.0
,Not Determined,19474531,[],CHEMBL4479319,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx preincubated for 30 mins prior to ATP-stimulation by calcium influx assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC1=CCC(C(=O)/N=C2\CC=C(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c32)=C/C1=N/C(=O)C1=CC=C/C(=N\C(=O)/N=C2\C=CC=C(C(=O)/N=C3/CC(C(=O)/N=C4\CC=C(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c54)=CC=C3C)C2)C1,,,CHEMBL4477234,J Med Chem,2016.0,,CHEMBL3040216,,CHEMBL3040216,,0,,3256521,,1,0,,,IC50,,,,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,,,,
,Not Determined,19474532,[],CHEMBL4479319,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx preincubated for 30 mins prior to ATP-stimulation by calcium influx assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(=O)Nc2ccc(S(=O)(=O)[O-])cc2)cc(C(=O)Nc2ccc(S(=O)(=O)[O-])cc2)c1)Nc1cc(C(=O)Nc2ccc(S(=O)(=O)[O-])cc2)cc(C(=O)Nc2ccc(S(=O)(=O)[O-])cc2)c1.[Na+].[Na+].[Na+].[Na+],,,CHEMBL4477234,J Med Chem,2016.0,,CHEMBL4160315,,CHEMBL4300424,,0,,3256523,,1,0,,,IC50,,,,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,,,,
,,19474533,[],CHEMBL4479319,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx preincubated for 30 mins prior to ATP-stimulation by calcium influx assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CN=C(c2cccc(Br)c2)c2oc3ccccc3c2N1,,,CHEMBL4477234,J Med Chem,2016.0,"{'bei': '18.18', 'le': '0.40', 'lle': '2.48', 'sei': '11.83'}",CHEMBL2180179,,CHEMBL2180179,6.46,0,http://www.openphacts.org/units/Nanomolar,3256524,=,1,1,=,,IC50,nM,,348.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.348
,,19474535,[],CHEMBL4479321,Antagonist activity at human P2X4 receptor expressed in CHO cells assessed as inhibition of ATP-induced calcium influx,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CN=C(c2cccc(Br)c2)c2oc3ccccc3c2N1,,,CHEMBL4477234,J Med Chem,2016.0,"{'bei': '17.74', 'le': '0.39', 'lle': '2.32', 'sei': '11.54'}",CHEMBL2180179,,CHEMBL2180179,6.30,1,http://www.openphacts.org/units/Nanomolar,3256524,=,1,1,=,,IC50,nM,,500.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.5
,,20648848,[],CHEMBL4615161,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020.0,"{'bei': '17.74', 'le': '0.37', 'lle': '1.47', 'sei': '13.80'}",CHEMBL536151,,CHEMBL536151,6.81,0,http://www.openphacts.org/units/Nanomolar,3475704,=,1,1,=,,IC50,nM,,156.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.156
,,20648849,[],CHEMBL4615161,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccccc1O,,,CHEMBL4613266,J Med Chem,2020.0,"{'bei': '19.50', 'le': '0.39', 'lle': '2.13', 'sei': '13.80'}",CHEMBL461542,,CHEMBL461542,6.81,0,http://www.openphacts.org/units/Nanomolar,3475707,=,1,1,=,,IC50,nM,,155.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.155
,,20648850,[],CHEMBL4615161,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cccc(Cl)c1O,,,CHEMBL4613266,J Med Chem,2020.0,"{'bei': '19.06', 'le': '0.40', 'lle': '1.97', 'sei': '14.82'}",CHEMBL2338695,,CHEMBL2338695,7.31,0,http://www.openphacts.org/units/Nanomolar,3475714,=,1,1,=,,IC50,nM,,48.8,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.0488
,,20648851,[],CHEMBL4615161,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccc(Cl)cc1O,,,CHEMBL4613266,J Med Chem,2020.0,"{'bei': '17.41', 'le': '0.36', 'lle': '1.34', 'sei': '13.54'}",CHEMBL2338696,,CHEMBL2338696,6.68,0,http://www.openphacts.org/units/Nanomolar,3475715,=,1,1,=,,IC50,nM,,209.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.209
,,20648852,[],CHEMBL4615161,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cccc(F)c1O,,,CHEMBL4613266,J Med Chem,2020.0,,CHEMBL4644398,,CHEMBL4644398,,0,http://www.openphacts.org/units/Nanomolar,3475723,>=,1,1,>=,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,10.0
,,20648853,[],CHEMBL4615161,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccc2ccccc2c1O,,,CHEMBL4613266,J Med Chem,2020.0,"{'bei': '15.37', 'le': '0.30', 'lle': '0.30', 'sei': '12.44'}",CHEMBL2338686,,CHEMBL2338686,6.14,0,http://www.openphacts.org/units/Nanomolar,3475726,=,1,1,=,,IC50,nM,,729.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.729
,,20648854,[],CHEMBL4615161,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cccc(C(F)(F)F)c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020.0,"{'bei': '19.86', 'le': '0.41', 'lle': '1.95', 'sei': '12.71'}",CHEMBL589733,,CHEMBL589733,6.27,0,http://www.openphacts.org/units/Nanomolar,3475732,=,1,1,=,,IC50,nM,,537.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.537
,,20648855,[],CHEMBL4615161,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1ccc(C(F)(F)F)cc1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020.0,"{'bei': '18.45', 'le': '0.38', 'lle': '1.50', 'sei': '11.81'}",CHEMBL2088014,,CHEMBL2088014,5.82,0,http://www.openphacts.org/units/Nanomolar,3475735,=,1,1,=,,IC50,nM,,1500.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,1.5
,,20648856,[],CHEMBL4615161,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc([N+](=O)[O-])cc(C(F)(F)F)c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020.0,"{'bei': '20.44', 'le': '0.42', 'lle': '3.15', 'sei': '7.97'}",CHEMBL4640175,,CHEMBL4640175,7.37,0,http://www.openphacts.org/units/Nanomolar,3475740,=,1,1,=,,IC50,nM,,42.6,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.0426
,,20648857,[],CHEMBL4615161,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(Cl)cc(Cl)c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020.0,"{'bei': '19.42', 'le': '0.44', 'lle': '1.55', 'sei': '12.46'}",CHEMBL2179173,,CHEMBL2179173,6.15,0,http://www.openphacts.org/units/Nanomolar,3475742,=,1,1,=,,IC50,nM,,712.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.712
,,20648858,[],CHEMBL4615161,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(F)cc(F)c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020.0,"{'bei': '24.01', 'le': '0.49', 'lle': '3.23', 'sei': '13.80'}",CHEMBL2179174,,CHEMBL2179174,6.81,0,http://www.openphacts.org/units/Nanomolar,3475744,=,1,1,=,,IC50,nM,,155.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.155
,,20648859,[],CHEMBL4615161,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cccc(Cl)c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020.0,"{'bei': '24.35', 'le': '0.52', 'lle': '2.92', 'sei': '13.93'}",CHEMBL2088011,,CHEMBL2088011,6.87,0,http://www.openphacts.org/units/Nanomolar,3475750,=,1,1,=,,IC50,nM,,135.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.135
,,22923686,[],CHEMBL4737215,Antagonist activity at human P2X4 receptor expressed in rat C6-BU-1 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Oc1ccc(Nc2nc(=O)n(CC(C)(C)C(=O)O)c(=O)n2Cc2ccc(Cl)cc2)cc1F,,,CHEMBL4732178,Bioorg Med Chem Lett,2021.0,,CHEMBL3985699,,CHEMBL3985699,,0,http://www.openphacts.org/units/Nanomolar,3559272,>,1,1,>,,IC50,nM,,30000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,30000.0
,,22923687,[],CHEMBL4737215,Antagonist activity at human P2X4 receptor expressed in rat C6-BU-1 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(Cn2c(Nc3ccc(OC(C)C)c(Cl)c3)nc(=O)n(CCC(=O)O)c2=O)cc1,,,CHEMBL4732178,Bioorg Med Chem Lett,2021.0,,CHEMBL4748113,,CHEMBL4748113,,0,http://www.openphacts.org/units/Nanomolar,3559273,>,1,1,>,,IC50,nM,,30000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,30000.0
,,22923688,[],CHEMBL4737215,Antagonist activity at human P2X4 receptor expressed in rat C6-BU-1 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(C(C)C)c(Oc2cnc(NC(CO)CO)nc2N)cc1I,,,CHEMBL4732178,Bioorg Med Chem Lett,2021.0,,CHEMBL494161,,CHEMBL494161,,0,http://www.openphacts.org/units/Nanomolar,3559274,>,1,1,>,,IC50,nM,,10000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,10000.0
,Active,23325965,[],CHEMBL4880851,Fluorometric imaging plate reader (FLIPR)-based Ca2+ assay with HEK293 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1,,,CHEMBL4507265,,2021.0,,CHEMBL4521594,BAY-1797,CHEMBL4521594,,0,http://www.openphacts.org/units/Nanomolar,3359659,,54,1,,,IC50,nM,,211.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,211.0
,Active,23325966,[],CHEMBL4880852,Fluorometric imaging plate reader (FLIPR)-based Ca2+ assay with 1321 N1 Astrocytoma cells,B,,,BAO_0000190,BAO_0000019,assay format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1,,,CHEMBL4507265,,2021.0,,CHEMBL4521594,BAY-1797,CHEMBL4521594,,0,http://www.openphacts.org/units/Nanomolar,3359659,,54,1,,,IC50,nM,,108.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,108.0
,Active,23325967,[],CHEMBL4880853,Ephys Qpatch Assay with HEK293 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1,,,CHEMBL4507265,,2021.0,,CHEMBL4521594,BAY-1797,CHEMBL4521594,,0,http://www.openphacts.org/units/Nanomolar,3359659,,54,1,,,IC50,nM,,274.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,274.0
,Active,23325968,[],CHEMBL4880854,Ephys Qpatch Assay with 1321 N1 Astrocytoma cells,B,,,BAO_0000190,BAO_0000019,assay format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1,,,CHEMBL4507265,,2021.0,,CHEMBL4521594,BAY-1797,CHEMBL4521594,,0,http://www.openphacts.org/units/Nanomolar,3359659,,54,1,,,IC50,nM,,320.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,320.0
,Not Active,23325976,[],CHEMBL4880855,Fluorometric imaging plate reader (FLIPR)-based Ca2+ assay,B,,,BAO_0000190,BAO_0000357,single protein format,NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1,,,CHEMBL4507265,,2021.0,,CHEMBL4516843,BAY-207,CHEMBL4516843,,0,,3359660,,54,0,,,IC50,µM,,25.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,µM,,,25.0
,,24349807,[],CHEMBL5031928,Antagonist activity at P2X4 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(Cn2c(Nc3ccc(OC(C)C)c(Cl)c3)nc(=O)n(CCC(=O)O)c2=O)cc1,,,CHEMBL5030545,Bioorg Med Chem Lett,2021.0,,CHEMBL4748113,,CHEMBL4748113,,1,http://www.openphacts.org/units/Nanomolar,3772443,>,1,1,>,,IC50,nM,,30000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,30000.0
,,24349808,[],CHEMBL5031928,Antagonist activity at P2X4 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Cn1c(=O)[nH]/c(=N\c2ccc(Oc3ccsn3)cc2)n(Cc2ccc(Cl)cc2)c1=O)C(=O)O,,,CHEMBL5030545,Bioorg Med Chem Lett,2021.0,,CHEMBL5073093,,CHEMBL5073093,,0,http://www.openphacts.org/units/Nanomolar,3772429,>,1,1,>,,IC50,nM,,30000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,30000.0
,,24349809,[],CHEMBL5031928,Antagonist activity at P2X4 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Cn1c(=O)[nH]/c(=N\c2ccc(Oc3ccccn3)cc2)n(Cc2ccc(Cl)cc2)c1=O)C(=O)O,,,CHEMBL5030545,Bioorg Med Chem Lett,2021.0,,CHEMBL5084939,,CHEMBL5084939,,0,http://www.openphacts.org/units/Nanomolar,3772430,>,1,1,>,,IC50,nM,,30000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,30000.0
,,24349810,[],CHEMBL5031928,Antagonist activity at P2X4 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Cn1c(=O)[nH]/c(=N\c2ccc(Oc3ccnc(F)c3)cc2)n(Cc2ccc(Cl)cc2)c1=O)C(=O)O,,,CHEMBL5030545,Bioorg Med Chem Lett,2021.0,,CHEMBL5084053,,CHEMBL5084053,,0,http://www.openphacts.org/units/Nanomolar,3772440,>,1,1,>,,IC50,nM,,30000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,30000.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24697025,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5106928,Antagonist activity at human P2X4R transfected in HEK293 cells preincubated for 30 mins followed by CTP addition by fluorescence based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@H]2OC3(O[C@H]21)C([N+](=O)[O-])=CC([N+](=O)[O-])C=C3[N+](=O)[O-],,,CHEMBL5104186,J Med Chem,2022.0,"{'bei': '7.74', 'le': '0.17', 'lle': '6.45', 'sei': '1.44'}",CHEMBL337395,,CHEMBL337395,5.56,0,http://www.openphacts.org/units/Nanomolar,3851065,=,1,1,=,,IC50,nM,,2770.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,2.77
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24697026,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5106928,Antagonist activity at human P2X4R transfected in HEK293 cells preincubated for 30 mins followed by CTP addition by fluorescence based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CC(=O)N(c2cccc(-c3noc(=S)[n-]3)c2)c2ccc3ccccc3c2N1.[Na+],,,CHEMBL5104186,J Med Chem,2022.0,"{'bei': '14.59', 'le': '0.28', 'lle': '1.31', 'sei': '6.43'}",CHEMBL4462656,,CHEMBL4596410,5.87,0,http://www.openphacts.org/units/Nanomolar,3851066,=,1,1,=,,IC50,nM,,1350.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,1.35
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24697027,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5106928,Antagonist activity at human P2X4R transfected in HEK293 cells preincubated for 30 mins followed by CTP addition by fluorescence based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc2ccc3c(c2c1)NC(=O)CC(=O)N3c1cccc(-c2noc(=S)[n-]2)c1.[Na+],,,CHEMBL5104186,J Med Chem,2022.0,"{'bei': '11.40', 'le': '0.22', 'lle': '-0.12', 'sei': '5.20'}",CHEMBL5198714,,CHEMBL5222332,4.75,0,http://www.openphacts.org/units/Nanomolar,3851067,=,1,1,=,,IC50,nM,,17900.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,17.9
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24697028,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5106928,Antagonist activity at human P2X4R transfected in HEK293 cells preincubated for 30 mins followed by CTP addition by fluorescence based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc2c3c(ccc2c1)N(c1cccc(-c2noc(=S)[n-]2)c1)C(=O)CC(=O)N3.[Na+],,,CHEMBL5104186,J Med Chem,2022.0,"{'bei': '14.07', 'le': '0.27', 'lle': '0.99', 'sei': '6.42'}",CHEMBL5183364,,CHEMBL5221819,5.86,0,http://www.openphacts.org/units/Nanomolar,3851068,=,1,1,=,,IC50,nM,,1380.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,1.38
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24697029,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5106928,Antagonist activity at human P2X4R transfected in HEK293 cells preincubated for 30 mins followed by CTP addition by fluorescence based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)CC.O=C1CC(=O)N(c2cccc(-c3noc(=S)[nH]3)c2)c2cc(Br)c3ccccc3c2N1,,,CHEMBL5104186,J Med Chem,2022.0,"{'bei': '10.43', 'le': '0.23', 'lle': '-0.30', 'sei': '5.50'}",CHEMBL5209437,,CHEMBL5222776,5.02,0,http://www.openphacts.org/units/Nanomolar,3851069,=,1,1,=,,IC50,nM,,9510.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,9.51
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24697030,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5106928,Antagonist activity at human P2X4R transfected in HEK293 cells preincubated for 30 mins followed by CTP addition by fluorescence based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)CC.Cc1ccc2c(Br)cc3c(c2c1)NC(=O)CC(=O)N3c1cccc(-c2noc(=S)[nH]2)c1,,,CHEMBL5104186,J Med Chem,2022.0,"{'bei': '9.95', 'le': '0.22', 'lle': '-0.70', 'sei': '5.40'}",CHEMBL5172632,,CHEMBL5221206,4.93,0,http://www.openphacts.org/units/Nanomolar,3851070,=,1,1,=,,IC50,nM,,11800.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,11.8
,ND,24697031,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5106928,Antagonist activity at human P2X4R transfected in HEK293 cells preincubated for 30 mins followed by CTP addition by fluorescence based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)CC.CSCc1ccc2ccc3c(c2c1)NC(=O)CC(=O)N3c1cccc(-c2noc(=S)[nH]2)c1,,,CHEMBL5104186,J Med Chem,2022.0,,CHEMBL5197073,,CHEMBL5222375,,0,,3851071,,1,0,,,IC50,,,,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,,,,
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24697032,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5106928,Antagonist activity at human P2X4R transfected in HEK293 cells preincubated for 30 mins followed by CTP addition by fluorescence based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)CC.[N-]=[N+]=NCc1ccc2c3c(ccc2c1)N(c1cccc(-c2noc(=S)[nH]2)c1)C(=O)CC(=O)N3,,,CHEMBL5104186,J Med Chem,2022.0,"{'bei': '10.21', 'le': '0.19', 'lle': '-0.70', 'sei': '3.34'}",CHEMBL5196647,,CHEMBL5222195,4.67,0,http://www.openphacts.org/units/Nanomolar,3851075,=,1,1,=,,IC50,nM,,21300.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,21.3
,ND,24697033,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5106928,Antagonist activity at human P2X4R transfected in HEK293 cells preincubated for 30 mins followed by CTP addition by fluorescence based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)CC.[N-]=[N+]=NCc1ccc2c3c(cc(Br)c2c1)N(c1cccc(-c2noc(=S)[nH]2)c1)C(=O)CC(=O)N3,,,CHEMBL5104186,J Med Chem,2022.0,,CHEMBL5193263,,CHEMBL5222482,,0,,3851076,,1,0,,,IC50,,,,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,,,,
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24697034,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5106928,Antagonist activity at human P2X4R transfected in HEK293 cells preincubated for 30 mins followed by CTP addition by fluorescence based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)CC.O=C1CC(=O)N(c2cccc(-c3noc(=S)[nH]3)c2)c2cc(-c3ccccc3)c3ccccc3c2N1,,,CHEMBL5104186,J Med Chem,2022.0,"{'bei': '9.79', 'le': '0.18', 'lle': '-1.55', 'sei': '5.13'}",CHEMBL5202820,,CHEMBL5222685,4.68,0,http://www.openphacts.org/units/Nanomolar,3851077,=,1,1,=,,IC50,nM,,20700.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,20.7
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24697035,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5106928,Antagonist activity at human P2X4R transfected in HEK293 cells preincubated for 30 mins followed by CTP addition by fluorescence based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)CC.CCc1cc2c(c3ccccc13)NC(=O)CC(=O)N2c1cccc(-c2noc(=S)[nH]2)c1,,,CHEMBL5104186,J Med Chem,2022.0,"{'bei': '12.29', 'le': '0.23', 'lle': '0.17', 'sei': '5.80'}",CHEMBL5182981,,CHEMBL5221973,5.29,0,http://www.openphacts.org/units/Nanomolar,3851081,=,1,1,=,,IC50,nM,,5130.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,5.13
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24697036,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5106928,Antagonist activity at human P2X4R transfected in HEK293 cells preincubated for 30 mins followed by CTP addition by fluorescence based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)CC.Cc1cc(-c2noc(=S)[nH]2)cc(N2C(=O)CC(=O)Nc3c2ccc2ccccc32)c1,,,CHEMBL5104186,J Med Chem,2022.0,"{'bei': '11.66', 'le': '0.22', 'lle': '-0.02', 'sei': '5.32'}",CHEMBL5200459,,CHEMBL5222559,4.85,0,http://www.openphacts.org/units/Nanomolar,3851083,=,1,1,=,,IC50,nM,,14000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,14.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24697037,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5106928,Antagonist activity at human P2X4R transfected in HEK293 cells preincubated for 30 mins followed by CTP addition by fluorescence based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)CC.O=C1CC(=O)N(c2cc(-c3noc(=S)[nH]3)ccn2)c2ccc3ccccc3c2N1,,,CHEMBL5104186,J Med Chem,2022.0,"{'bei': '12.07', 'le': '0.23', 'lle': '0.92', 'sei': '4.68'}",CHEMBL5198347,,CHEMBL5222330,4.87,0,http://www.openphacts.org/units/Nanomolar,3851084,=,1,1,=,,IC50,nM,,13500.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,13.5
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24697038,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5106928,Antagonist activity at human P2X4R transfected in HEK293 cells preincubated for 30 mins followed by CTP addition by fluorescence based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)CC.O=C1CC(=O)N(c2cncc(-c3noc(=S)[nH]3)c2)c2ccc3ccccc3c2N1,,,CHEMBL5104186,J Med Chem,2022.0,"{'bei': '11.99', 'le': '0.23', 'lle': '0.89', 'sei': '4.64'}",CHEMBL5184461,,CHEMBL5221928,4.84,0,http://www.openphacts.org/units/Nanomolar,3851085,=,1,1,=,,IC50,nM,,14600.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,14.6
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24697039,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5106928,Antagonist activity at human P2X4R transfected in HEK293 cells preincubated for 30 mins followed by CTP addition by fluorescence based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)CC.O=C1CC(=O)N(c2ccnc(-c3noc(=S)[nH]3)c2)c2ccc3ccccc3c2N1,,,CHEMBL5104186,J Med Chem,2022.0,"{'bei': '15.61', 'le': '0.30', 'lle': '2.35', 'sei': '6.05'}",CHEMBL5179436,,CHEMBL5221727,6.30,0,http://www.openphacts.org/units/Nanomolar,3851086,=,1,1,=,,IC50,nM,,503.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.503
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24697040,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5106928,Antagonist activity at human P2X4R transfected in HEK293 cells preincubated for 30 mins followed by CTP addition by fluorescence based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)CC.O=C1CC(=O)N(c2cccc(-c3noc(=S)[nH]3)n2)c2ccc3ccccc3c2N1,,,CHEMBL5104186,J Med Chem,2022.0,"{'bei': '12.86', 'le': '0.24', 'lle': '1.24', 'sei': '4.98'}",CHEMBL5194243,,CHEMBL5222284,5.19,0,http://www.openphacts.org/units/Nanomolar,3851087,=,1,1,=,,IC50,nM,,6480.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,6.48
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24697069,[],CHEMBL5106947,Antagonist activity at P2X4R (unknown origin) expressed in 1321N1 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CN=C(c2cccc(Br)c2)c2oc3ccccc3c2N1,,,CHEMBL5104186,J Med Chem,2022.0,"{'bei': '14.88', 'le': '0.33', 'lle': '1.30', 'sei': '9.68'}",CHEMBL2180179,,CHEMBL2180179,5.28,0,http://www.openphacts.org/units/Nanomolar,3851088,=,1,1,=,,IC50,nM,,5200.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,5.2
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24697070,[],CHEMBL5106947,Antagonist activity at P2X4R (unknown origin) expressed in 1321N1 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1cc(Br)c(NC(=O)Nc2cccnc2)c(Br)c1,,,CHEMBL5104186,J Med Chem,2022.0,"{'bei': '13.82', 'le': '0.37', 'lle': '0.34', 'sei': '10.57'}",CHEMBL1532400,,CHEMBL1532400,5.71,0,http://www.openphacts.org/units/Nanomolar,3851089,=,1,1,=,,IC50,nM,,1950.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,1.95
,,24770280,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5126051,Agonist activity at human P2X4R expressing HEK293 cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by compound addition and further incubated for 30 mins in presence of ATP by multimode plate reader analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(C(=O)O[C@@H]2[C@H](OC(=O)c3ccc(OC)cc3)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O[C@H]2n2cnc3c(N)ncnc32)cc1,,,CHEMBL5120960,J Med Chem,2022.0,,CHEMBL5197509,,CHEMBL5197509,,0,http://www.openphacts.org/units/Nanomolar,3864896,<,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,pIC50,,UO_0000065,,4.0
"{'action_type': 'AGONIST', 'description': 'Binds to and activates a receptor, often mimicking the effect of the endogenous ligand', 'parent_type': 'POSITIVE MODULATOR'}",,24770281,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5126051,Agonist activity at human P2X4R expressing HEK293 cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by compound addition and further incubated for 30 mins in presence of ATP by multimode plate reader analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1F,,,CHEMBL5120960,J Med Chem,2022.0,"{'bei': '10.92', 'le': '0.24', 'lle': '6.21', 'sei': '2.15'}",CHEMBL4576110,,CHEMBL4576110,5.56,0,http://www.openphacts.org/units/Nanomolar,3864898,=,1,1,=,,IC50,nM,,2754.23,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,pIC50,,UO_0000065,,5.56
,,24770282,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5126051,Agonist activity at human P2X4R expressing HEK293 cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by compound addition and further incubated for 30 mins in presence of ATP by multimode plate reader analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1N,,,CHEMBL5120960,J Med Chem,2022.0,,CHEMBL4582937,,CHEMBL4582937,,0,http://www.openphacts.org/units/Nanomolar,3864900,<,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,pIC50,,UO_0000065,,4.0
,,24770283,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5126051,Agonist activity at human P2X4R expressing HEK293 cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by compound addition and further incubated for 30 mins in presence of ATP by multimode plate reader analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CO[C@@H]1[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O[C@H]1n1cnc2c(N)ncnc21,,,CHEMBL5120960,J Med Chem,2022.0,,CHEMBL3142844,,CHEMBL3142844,,0,http://www.openphacts.org/units/Nanomolar,3864901,<,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,pIC50,,UO_0000065,,4.0
"{'action_type': 'AGONIST', 'description': 'Binds to and activates a receptor, often mimicking the effect of the endogenous ligand', 'parent_type': 'POSITIVE MODULATOR'}",,24770284,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5126051,Agonist activity at human P2X4R expressing HEK293 cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by compound addition and further incubated for 30 mins in presence of ATP by multimode plate reader analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@@H]1O,,,CHEMBL5120960,J Med Chem,2022.0,"{'bei': '9.82', 'le': '0.22', 'lle': '6.61', 'sei': '1.78'}",CHEMBL4441501,,CHEMBL4441501,4.98,0,http://www.openphacts.org/units/Nanomolar,3864902,=,1,1,=,,IC50,nM,,10471.29,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,pIC50,,UO_0000065,,4.98
,,24770285,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5126051,Agonist activity at human P2X4R expressing HEK293 cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by compound addition and further incubated for 30 mins in presence of ATP by multimode plate reader analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=P(O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(Cl)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL5120960,J Med Chem,2022.0,,CHEMBL1160555,,CHEMBL1160555,,0,http://www.openphacts.org/units/Nanomolar,3864903,<,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,pIC50,,UO_0000065,,4.0
,,24770286,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5126051,Agonist activity at human P2X4R expressing HEK293 cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by compound addition and further incubated for 30 mins in presence of ATP by multimode plate reader analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=P(O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(S)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL5120960,J Med Chem,2022.0,,CHEMBL4583478,,CHEMBL4583478,,0,http://www.openphacts.org/units/Nanomolar,3864904,<,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,pIC50,,UO_0000065,,4.0
,,24770287,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5126051,Agonist activity at human P2X4R expressing HEK293 cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by compound addition and further incubated for 30 mins in presence of ATP by multimode plate reader analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CNc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O,,,CHEMBL5120960,J Med Chem,2022.0,,CHEMBL1199042,,CHEMBL1199042,,0,http://www.openphacts.org/units/Nanomolar,3864905,<,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,pIC50,,UO_0000065,,4.0
,,24770288,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5126051,Agonist activity at human P2X4R expressing HEK293 cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by compound addition and further incubated for 30 mins in presence of ATP by multimode plate reader analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCNc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O,,,CHEMBL5120960,J Med Chem,2022.0,,CHEMBL5171786,,CHEMBL5171786,,0,http://www.openphacts.org/units/Nanomolar,3864906,<,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,pIC50,,UO_0000065,,4.0
"{'action_type': 'AGONIST', 'description': 'Binds to and activates a receptor, often mimicking the effect of the endogenous ligand', 'parent_type': 'POSITIVE MODULATOR'}",,24770289,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5126051,Agonist activity at human P2X4R expressing HEK293 cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by compound addition and further incubated for 30 mins in presence of ATP by multimode plate reader analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=P(O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL5120960,J Med Chem,2022.0,"{'bei': '10.37', 'le': '0.22', 'lle': '5.52', 'sei': '2.28'}",CHEMBL5202979,,CHEMBL5202979,6.05,0,http://www.openphacts.org/units/Nanomolar,3864907,=,1,1,=,,IC50,nM,,891.25,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,pIC50,,UO_0000065,,6.05
,,24770290,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5126051,Agonist activity at human P2X4R expressing HEK293 cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by compound addition and further incubated for 30 mins in presence of ATP by multimode plate reader analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=P(O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(NCc4ccccc4)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL5120960,J Med Chem,2022.0,,CHEMBL5170304,,CHEMBL5170304,,0,http://www.openphacts.org/units/Nanomolar,3864908,<,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,pIC50,,UO_0000065,,4.0
,,24770291,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5126051,Agonist activity at human P2X4R expressing HEK293 cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by compound addition and further incubated for 30 mins in presence of ATP by multimode plate reader analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=P(O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c2ncn2ccnc32)[C@H](O)[C@@H]1O,,,CHEMBL5120960,J Med Chem,2022.0,,CHEMBL5200154,,CHEMBL5200154,,0,http://www.openphacts.org/units/Nanomolar,3864909,<,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,pIC50,,UO_0000065,,4.0
,,24770292,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5126051,Agonist activity at human P2X4R expressing HEK293 cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by compound addition and further incubated for 30 mins in presence of ATP by multimode plate reader analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,[N-]=[N+]=Nc1nc2c(N)ncnc2n1[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O,,,CHEMBL5120960,J Med Chem,2022.0,,CHEMBL4567276,,CHEMBL4567276,,0,http://www.openphacts.org/units/Nanomolar,3864910,<,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,pIC50,,UO_0000065,,4.0
,,24770293,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5126051,Agonist activity at human P2X4R expressing HEK293 cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by compound addition and further incubated for 30 mins in presence of ATP by multimode plate reader analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=c1[nH]c2cncnc2n1[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O,,,CHEMBL5120960,J Med Chem,2022.0,,CHEMBL5170556,,CHEMBL5170556,,0,http://www.openphacts.org/units/Nanomolar,3864911,<,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,pIC50,,UO_0000065,,4.0
,,24770340,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5126058,Antagonist activity at human P2X4R expressing HEK293 cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by compound addition and further incubated for 30 mins in presence of ATP by multimode plate reader analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](OC(=O)c2ccccc2)[C@H]1OC(=O)c1ccccc1,,,CHEMBL5120960,J Med Chem,2022.0,,CHEMBL5177316,,CHEMBL5177316,,0,http://www.openphacts.org/units/Nanomolar,3864899,<,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,pIC50,,UO_0000065,,4.0
,,24770341,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5126058,Antagonist activity at human P2X4R expressing HEK293 cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by compound addition and further incubated for 30 mins in presence of ATP by multimode plate reader analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(C(=O)O[C@@H]2[C@H](OC(=O)c3ccc(OC)cc3)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O[C@H]2n2cnc3c(N)ncnc32)cc1,,,CHEMBL5120960,J Med Chem,2022.0,,CHEMBL5197509,,CHEMBL5197509,,0,http://www.openphacts.org/units/Nanomolar,3864896,<,1,1,>,,IC50,nM,,100000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,pIC50,,UO_0000065,,4.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24770342,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5126058,Antagonist activity at human P2X4R expressing HEK293 cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by compound addition and further incubated for 30 mins in presence of ATP by multimode plate reader analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](OC(=O)c2cccc3ccccc23)[C@H]1OC(=O)c1cccc2ccccc12,,,CHEMBL5120960,J Med Chem,2022.0,"{'bei': '6.38', 'le': '0.13', 'lle': '0.79', 'sei': '1.79'}",CHEMBL5183218,,CHEMBL5183218,5.20,0,http://www.openphacts.org/units/Nanomolar,3864897,=,1,1,=,,IC50,nM,,6309.57,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,pIC50,,UO_0000065,,5.2
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24801346,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5134929,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as reduction in intracellular Ca2+ influx incubated for 30 mins by Fura-2 AM based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC(=S)Nc1ccccc1O)C12CC3CC(CC(C3)C1)C2,,,CHEMBL5131484,Eur J Med Chem,2022.0,"{'bei': '18.05', 'le': '0.35', 'lle': '2.54', 'sei': '9.72'}",CHEMBL5174595,,CHEMBL5174595,5.96,0,http://www.openphacts.org/units/Nanomolar,3871686,=,1,1,=,,IC50,nM,,1084.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,1.084
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24801347,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5134929,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as reduction in intracellular Ca2+ influx incubated for 30 mins by Fura-2 AM based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC(=S)Nc1cc(Cl)c(O)c(Cl)c1)C12CC3CC(CC(C3)C1)C2,,,CHEMBL5131484,Eur J Med Chem,2022.0,"{'bei': '14.75', 'le': '0.32', 'lle': '1.16', 'sei': '9.60'}",CHEMBL5174645,,CHEMBL5174645,5.89,0,http://www.openphacts.org/units/Nanomolar,3871689,=,1,1,=,,IC50,nM,,1282.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,1.2819999999999998
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24801348,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5134929,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as reduction in intracellular Ca2+ influx incubated for 30 mins by Fura-2 AM based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC(=S)Nc1cc(Br)cc(C(F)(F)F)c1)C12CC3CC(CC(C3)C1)C2,,,CHEMBL5131484,Eur J Med Chem,2022.0,"{'bei': '11.58', 'le': '0.27', 'lle': '-0.16', 'sei': '12.99'}",CHEMBL5206955,,CHEMBL5206955,5.34,0,http://www.openphacts.org/units/Nanomolar,3871690,=,1,1,=,,IC50,nM,,4530.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,4.53
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24801349,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5134929,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as reduction in intracellular Ca2+ influx incubated for 30 mins by Fura-2 AM based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1ccccc1NC(=S)NC(=O)C12CC3CC(CC(C3)C1)C2,,,CHEMBL5131484,Eur J Med Chem,2022.0,"{'bei': '13.67', 'le': '0.28', 'lle': '3.02', 'sei': '5.31'}",CHEMBL5184546,,CHEMBL5184546,5.38,0,http://www.openphacts.org/units/Nanomolar,3871691,=,1,1,=,,IC50,nM,,4187.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,4.187
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24801350,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5134929,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as reduction in intracellular Ca2+ influx incubated for 30 mins by Fura-2 AM based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC(=S)Nc1cc([N+](=O)[O-])ccc1Cl)C12CC3CC(CC(C3)C1)C2,,,CHEMBL5131484,Eur J Med Chem,2022.0,"{'bei': '14.95', 'le': '0.31', 'lle': '1.61', 'sei': '6.99'}",CHEMBL5175938,,CHEMBL5175938,5.89,0,http://www.openphacts.org/units/Nanomolar,3871692,=,1,1,=,,IC50,nM,,1290.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,1.29
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24801351,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5134929,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as reduction in intracellular Ca2+ influx incubated for 30 mins by Fura-2 AM based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(NC(=S)NC(=O)C23CC4CC(CC(C4)C2)C3)cc1OC,,,CHEMBL5131484,Eur J Med Chem,2022.0,"{'bei': '14.58', 'le': '0.29', 'lle': '1.73', 'sei': '9.16'}",CHEMBL5200337,,CHEMBL5200337,5.46,0,http://www.openphacts.org/units/Nanomolar,3871695,=,1,1,=,,IC50,nM,,3461.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,3.4610000000000003
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24801352,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5134929,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as reduction in intracellular Ca2+ influx incubated for 30 mins by Fura-2 AM based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(NC(=S)NC(=O)C23CC4CC(CC(C4)C2)C3)c(Br)c1,,,CHEMBL5131484,Eur J Med Chem,2022.0,"{'bei': '14.25', 'le': '0.33', 'lle': '1.02', 'sei': '14.12'}",CHEMBL5172961,,CHEMBL5172961,5.81,0,http://www.openphacts.org/units/Nanomolar,3871697,=,1,1,=,,IC50,nM,,1562.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,1.5619999999999998
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24801353,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5134929,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as reduction in intracellular Ca2+ influx incubated for 30 mins by Fura-2 AM based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC(=S)Nc1cc(Br)ccc1Br)C12CC3CC(CC(C3)C1)C2,,,CHEMBL5131484,Eur J Med Chem,2022.0,"{'bei': '10.75', 'le': '0.29', 'lle': '-0.16', 'sei': '12.35'}",CHEMBL5181561,,CHEMBL5181561,5.08,0,http://www.openphacts.org/units/Nanomolar,3871700,=,1,1,=,,IC50,nM,,8339.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,8.339
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24801354,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5134929,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as reduction in intracellular Ca2+ influx incubated for 30 mins by Fura-2 AM based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC(=S)Nc1cccnc1Cl)C12CC3CC(CC(C3)C1)C2,,,CHEMBL5131484,Eur J Med Chem,2022.0,"{'bei': '16.85', 'le': '0.35', 'lle': '2.13', 'sei': '10.91'}",CHEMBL5188202,,CHEMBL5188202,5.89,0,http://www.openphacts.org/units/Nanomolar,3871701,=,1,1,=,,IC50,nM,,1274.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,1.274
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24801355,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5134929,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as reduction in intracellular Ca2+ influx incubated for 30 mins by Fura-2 AM based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(/N=N/c2ccc(S(=O)(=O)O)cc2S(=O)(=O)O)c(COP(=O)(O)O)c(C=O)c1O,,,CHEMBL5131484,Eur J Med Chem,2022.0,"{'bei': '10.34', 'le': '0.23', 'lle': '3.25', 'sei': '2.22'}",CHEMBL1615626,,CHEMBL1615626,5.28,0,http://www.openphacts.org/units/Nanomolar,3871704,=,1,1,=,,IC50,nM,,5250.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,5.25
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24801356,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5134929,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as reduction in intracellular Ca2+ influx incubated for 30 mins by Fura-2 AM based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC1=CCC(C(=O)/N=C2\CC=C(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c32)=C/C1=N/C(=O)C1=CC=C/C(=N\C(=O)/N=C2\C=CC=C(C(=O)/N=C3/CC(C(=O)/N=C4\CC=C(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c54)=CC=C3C)C2)C1,,,CHEMBL5131484,Eur J Med Chem,2022.0,"{'bei': '4.05', 'le': None, 'lle': None, 'sei': None}",CHEMBL3040216,,CHEMBL3040216,5.25,0,http://www.openphacts.org/units/Nanomolar,3871705,=,1,1,=,,IC50,nM,,5640.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,5.64
,ND,24801357,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5134929,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as reduction in intracellular Ca2+ influx incubated for 30 mins by Fura-2 AM based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Nc4cccc(S(=O)O)c4)n3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O,,,CHEMBL5131484,Eur J Med Chem,2022.0,,CHEMBL5187239,,CHEMBL5187239,,0,,3871706,,1,0,,,IC50,,,,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,,,,
"{'action_type': 'NEGATIVE ALLOSTERIC MODULATOR', 'description': 'Reduces or prevents the action of the endogenous ligand of a receptor through binding to a site distinct from that ligand (non-competitive inhibition)', 'parent_type': 'NEGATIVE MODULATOR'}",,24801441,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5134953,Negative allosteric modulation activity at human P2X4 receptor expressed in human 1321N1 cells assessed as reduction in intracellular Ca2+ influx incubated for 30 mins by Fura-2 AM based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1ccc(NC(=S)NC(=O)C23CC4CC(CC(C4)C2)C3)c(Br)c1,,,CHEMBL5131484,Eur J Med Chem,2022.0,"{'bei': '16.99', 'le': '0.39', 'lle': '1.80', 'sei': '17.99'}",CHEMBL5204261,,CHEMBL5204261,7.40,0,http://www.openphacts.org/units/Nanomolar,3871699,=,1,1,=,,IC50,nM,,40.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.04
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24801446,[],CHEMBL5134956,Antagonist activity at human P2X4 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1,,,CHEMBL5131484,Eur J Med Chem,2022.0,"{'bei': '16.01', 'le': '0.33', 'lle': '2.72', 'sei': '6.78'}",CHEMBL4521594,BAY-1797,CHEMBL4521594,6.68,0,http://www.openphacts.org/units/Nanomolar,3871709,=,1,1,=,,IC50,nM,,211.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,211.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24807421,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5135960,Inhibition of human P2X4 stably expressed in human HEK293 cells assessed as intracellular calcium flux incubated for 30 mins in presence of agonist Benzoylbenzoyl-ATP by Fluo8-AM dye based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N(c1ccn2nccc2c1)c1cc(NC(=O)Cc2c(Cl)cccc2Cl)ccn1,,,CHEMBL5131526,ACS Med Chem Lett,2022.0,"{'bei': '14.98', 'le': '0.30', 'lle': '1.90', 'sei': '8.55'}",CHEMBL5188664,,CHEMBL5188664,6.80,0,http://www.openphacts.org/units/Nanomolar,3872722,=,1,1,=,,IC50,nM,,157.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,157.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24807422,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5135960,Inhibition of human P2X4 stably expressed in human HEK293 cells assessed as intracellular calcium flux incubated for 30 mins in presence of agonist Benzoylbenzoyl-ATP by Fluo8-AM dye based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N(c1cc(NC(=O)Cc2c(Cl)cccc2Cl)ccn1)c1ccncc1F,,,CHEMBL5131526,ACS Med Chem Lett,2022.0,"{'bei': '15.62', 'le': '0.32', 'lle': '1.98', 'sei': '9.00'}",CHEMBL5204109,,CHEMBL5204109,6.77,0,http://www.openphacts.org/units/Nanomolar,3872723,=,1,1,=,,IC50,nM,,171.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,171.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24807423,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5135960,Inhibition of human P2X4 stably expressed in human HEK293 cells assessed as intracellular calcium flux incubated for 30 mins in presence of agonist Benzoylbenzoyl-ATP by Fluo8-AM dye based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N(c1ccc2ncoc2c1)c1cc(NC(=O)Cc2c(Cl)cccc2Cl)ccn1,,,CHEMBL5131526,ACS Med Chem Lett,2022.0,"{'bei': '15.05', 'le': '0.30', 'lle': '1.45', 'sei': '7.76'}",CHEMBL5208843,,CHEMBL5208843,6.85,0,http://www.openphacts.org/units/Nanomolar,3872724,=,1,1,=,,IC50,nM,,141.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,141.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24807424,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5135960,Inhibition of human P2X4 stably expressed in human HEK293 cells assessed as intracellular calcium flux incubated for 30 mins in presence of agonist Benzoylbenzoyl-ATP by Fluo8-AM dye based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N(c1ccc2ncoc2c1)c1cc(NC(=O)Cc2cccc(F)c2Cl)ccn1,,,CHEMBL5131526,ACS Med Chem Lett,2022.0,"{'bei': '15.60', 'le': '0.30', 'lle': '1.96', 'sei': '7.75'}",CHEMBL5208382,,CHEMBL5208382,6.84,0,http://www.openphacts.org/units/Nanomolar,3872725,=,1,1,=,,IC50,nM,,143.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,143.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24807425,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5135960,Inhibition of human P2X4 stably expressed in human HEK293 cells assessed as intracellular calcium flux incubated for 30 mins in presence of agonist Benzoylbenzoyl-ATP by Fluo8-AM dye based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N(c1ccc2ncoc2c1)c1cc(NC(=O)Cc2ccccc2Cl)ccn1,,,CHEMBL5131526,ACS Med Chem Lett,2022.0,"{'bei': '16.10', 'le': '0.31', 'lle': '2.03', 'sei': '7.67'}",CHEMBL5178725,,CHEMBL5178725,6.78,0,http://www.openphacts.org/units/Nanomolar,3872726,=,1,1,=,,IC50,nM,,168.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,168.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24807426,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5135960,Inhibition of human P2X4 stably expressed in human HEK293 cells assessed as intracellular calcium flux incubated for 30 mins in presence of agonist Benzoylbenzoyl-ATP by Fluo8-AM dye based FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N(c1ccc2ncsc2c1)c1cc(NC(=O)Cc2ccccc2Cl)ccn1,,,CHEMBL5131526,ACS Med Chem Lett,2022.0,"{'bei': '15.67', 'le': '0.31', 'lle': '1.64', 'sei': '9.11'}",CHEMBL5180532,,CHEMBL5180532,6.85,0,http://www.openphacts.org/units/Nanomolar,3872727,=,1,1,=,,IC50,nM,,142.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,142.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24821329,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5140232,Antagonist activity against human P2X4R stably transfected in human 1321N1 cells incubated for 30 mins by Fura-2 AM staining based calcium influx assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC(=S)Nc1ccccc1O)c1ccc2c(c1)OCO2,,,CHEMBL5137039,Eur J Med Chem,2022.0,"{'bei': '17.91', 'le': '0.35', 'lle': '3.41', 'sei': '7.10'}",CHEMBL5191762,,CHEMBL5191762,5.67,0,http://www.openphacts.org/units/Nanomolar,3876117,=,1,1,=,,IC50,nM,,2164.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,2.164
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24821330,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5140232,Antagonist activity against human P2X4R stably transfected in human 1321N1 cells incubated for 30 mins by Fura-2 AM staining based calcium influx assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC(=S)Nc1ccc(O)cc1)c1ccc2c(c1)OCO2,,,CHEMBL5137039,Eur J Med Chem,2022.0,"{'bei': '18.46', 'le': '0.36', 'lle': '3.59', 'sei': '7.32'}",CHEMBL5186938,,CHEMBL5186938,5.84,0,http://www.openphacts.org/units/Nanomolar,3876119,=,1,1,=,,IC50,nM,,1447.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,1.4469999999999998
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24821331,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5140232,Antagonist activity against human P2X4R stably transfected in human 1321N1 cells incubated for 30 mins by Fura-2 AM staining based calcium influx assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cccc(NC(=S)NC(=O)c2ccc3c(c2)OCO3)c1,,,CHEMBL5137039,Eur J Med Chem,2022.0,"{'bei': '14.93', 'le': '0.31', 'lle': '4.47', 'sei': '4.73'}",CHEMBL5194724,,CHEMBL5194724,5.66,0,http://www.openphacts.org/units/Nanomolar,3876120,=,1,1,=,,IC50,nM,,2171.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,2.171
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24821332,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5140232,Antagonist activity against human P2X4R stably transfected in human 1321N1 cells incubated for 30 mins by Fura-2 AM staining based calcium influx assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1ccc(CCNC(=S)NC(=O)c2ccc3c(c2)OCO3)cc1,,,CHEMBL5137039,Eur J Med Chem,2022.0,"{'bei': '14.67', 'le': '0.30', 'lle': '5.07', 'sei': '4.99'}",CHEMBL5174305,,CHEMBL5174305,5.98,0,http://www.openphacts.org/units/Nanomolar,3876121,=,1,1,=,,IC50,nM,,1054.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,1.054
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24821333,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5140232,Antagonist activity against human P2X4R stably transfected in human 1321N1 cells incubated for 30 mins by Fura-2 AM staining based calcium influx assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC(=S)Nc1cc(Br)cc(C(F)(F)F)c1)c1ccc2c(c1)OCO2,,,CHEMBL5137039,Eur J Med Chem,2022.0,"{'bei': '10.60', 'le': '0.25', 'lle': '0.42', 'sei': '7.95'}",CHEMBL5172890,,CHEMBL5172890,4.74,0,http://www.openphacts.org/units/Nanomolar,3876122,=,1,1,=,,IC50,nM,,18200.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,18.2
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24821334,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5140232,Antagonist activity against human P2X4R stably transfected in human 1321N1 cells incubated for 30 mins by Fura-2 AM staining based calcium influx assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC(=S)Nc1c(Br)ccc(C(F)(F)F)c1Br)c1ccc2c(c1)OCO2,,,CHEMBL5137039,Eur J Med Chem,2022.0,"{'bei': '13.80', 'le': '0.37', 'lle': '2.17', 'sei': '12.18'}",CHEMBL5200114,,CHEMBL5200114,7.26,0,http://www.openphacts.org/units/Nanomolar,3876123,=,1,1,=,,IC50,nM,,55.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.055
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24821335,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5140232,Antagonist activity against human P2X4R stably transfected in human 1321N1 cells incubated for 30 mins by Fura-2 AM staining based calcium influx assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC(=S)Nc1cc(Cl)c(O)c(Cl)c1)c1ccc2c(c1)OCO2,,,CHEMBL5137039,Eur J Med Chem,2022.0,"{'bei': '13.28', 'le': '0.29', 'lle': '1.57', 'sei': '6.41'}",CHEMBL5184613,,CHEMBL5184613,5.12,0,http://www.openphacts.org/units/Nanomolar,3876124,=,1,1,=,,IC50,nM,,7644.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,7.644
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24821336,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5140232,Antagonist activity against human P2X4R stably transfected in human 1321N1 cells incubated for 30 mins by Fura-2 AM staining based calcium influx assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1NC(=S)NC(=O)c1ccc2c(c1)OCO2,,,CHEMBL5137039,Eur J Med Chem,2022.0,"{'bei': '16.45', 'le': '0.32', 'lle': '2.89', 'sei': '7.90'}",CHEMBL5173949,,CHEMBL5173949,5.43,0,http://www.openphacts.org/units/Nanomolar,3876125,=,1,1,=,,IC50,nM,,3672.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,3.6719999999999997
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24821337,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5140232,Antagonist activity against human P2X4R stably transfected in human 1321N1 cells incubated for 30 mins by Fura-2 AM staining based calcium influx assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC(=S)Nc1ccc([N+](=O)[O-])cc1)c1ccc2c(c1)OCO2,,,CHEMBL5137039,Eur J Med Chem,2022.0,"{'bei': '15.71', 'le': '0.31', 'lle': '2.97', 'sei': '5.28'}",CHEMBL5208562,,CHEMBL5208562,5.42,0,http://www.openphacts.org/units/Nanomolar,3876128,=,1,1,=,,IC50,nM,,3763.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,3.763
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24821338,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5140232,Antagonist activity against human P2X4R stably transfected in human 1321N1 cells incubated for 30 mins by Fura-2 AM staining based calcium influx assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC(=S)Nc1ccc(Br)cc1)c1ccc2c(c1)OCO2,,,CHEMBL5137039,Eur J Med Chem,2022.0,"{'bei': '12.78', 'le': '0.30', 'lle': '1.55', 'sei': '8.13'}",CHEMBL5177180,,CHEMBL5177180,4.85,0,http://www.openphacts.org/units/Nanomolar,3876129,=,1,1,=,,IC50,nM,,14260.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,14.26
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24821339,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5140232,Antagonist activity against human P2X4R stably transfected in human 1321N1 cells incubated for 30 mins by Fura-2 AM staining based calcium influx assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(Br)ccc1NC(=S)NC(=O)c1ccc2c(c1)OCO2,,,CHEMBL5137039,Eur J Med Chem,2022.0,"{'bei': '12.32', 'le': '0.29', 'lle': '1.24', 'sei': '8.13'}",CHEMBL5191639,,CHEMBL5191639,4.85,0,http://www.openphacts.org/units/Nanomolar,3876130,=,1,1,=,,IC50,nM,,14260.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,14.26
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24821340,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5140232,Antagonist activity against human P2X4R stably transfected in human 1321N1 cells incubated for 30 mins by Fura-2 AM staining based calcium influx assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1ccc(NC(=S)NC(=O)c2ccc3c(c2)OCO3)c(Br)c1,,,CHEMBL5137039,Eur J Med Chem,2022.0,"{'bei': '17.59', 'le': '0.40', 'lle': '2.98', 'sei': '12.43'}",CHEMBL5206892,,CHEMBL5206892,7.41,0,http://www.openphacts.org/units/Nanomolar,3876131,=,1,1,=,,IC50,nM,,39.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.039
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24821341,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5140232,Antagonist activity against human P2X4R stably transfected in human 1321N1 cells incubated for 30 mins by Fura-2 AM staining based calcium influx assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC(=S)Nc1cccnc1Cl)c1ccc2c(c1)OCO2,,,CHEMBL5137039,Eur J Med Chem,2022.0,"{'bei': '17.96', 'le': '0.37', 'lle': '3.44', 'sei': '8.32'}",CHEMBL5205239,,CHEMBL5205239,6.03,0,http://www.openphacts.org/units/Nanomolar,3876132,=,1,1,=,,IC50,nM,,935.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.935
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24821342,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5140232,Antagonist activity against human P2X4R stably transfected in human 1321N1 cells incubated for 30 mins by Fura-2 AM staining based calcium influx assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC(=S)Nc1cccc2cccnc12)c1ccc2c(c1)OCO2,,,CHEMBL5137039,Eur J Med Chem,2022.0,"{'bei': '17.19', 'le': '0.33', 'lle': '2.95', 'sei': '8.34'}",CHEMBL5178892,,CHEMBL5178892,6.04,0,http://www.openphacts.org/units/Nanomolar,3876133,=,1,1,=,,IC50,nM,,908.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.9079999999999999
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24821343,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5140232,Antagonist activity against human P2X4R stably transfected in human 1321N1 cells incubated for 30 mins by Fura-2 AM staining based calcium influx assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(/N=N/c2ccc(S(=O)(=O)O)cc2S(=O)(=O)O)c(COP(=O)(O)O)c(C=O)c1O,,,CHEMBL5137039,Eur J Med Chem,2022.0,"{'bei': '10.20', 'le': '0.22', 'lle': '3.78', 'sei': '2.08'}",CHEMBL69234,,CHEMBL69234,5.21,0,http://www.openphacts.org/units/Nanomolar,3876134,=,1,1,=,,IC50,nM,,6100.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,6.1
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24821344,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5140232,Antagonist activity against human P2X4R stably transfected in human 1321N1 cells incubated for 30 mins by Fura-2 AM staining based calcium influx assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC1=CCC(C(=O)/N=C2\CC=C(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c32)=C/C1=N/C(=O)C1=CC=C/C(=N\C(=O)/N=C2\C=CC=C(C(=O)/N=C3/CC(C(=O)/N=C4\CC=C(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c54)=CC=C3C)C2)C1,,,CHEMBL5137039,Eur J Med Chem,2022.0,"{'bei': '4.10', 'le': None, 'lle': None, 'sei': None}",CHEMBL3040216,,CHEMBL3040216,5.33,0,http://www.openphacts.org/units/Nanomolar,3876135,=,1,1,=,,IC50,nM,,4730.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,4.73
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24821345,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5140232,Antagonist activity against human P2X4R stably transfected in human 1321N1 cells incubated for 30 mins by Fura-2 AM staining based calcium influx assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1cc(Br)c(NC(=O)Nc2cccnc2)c(Br)c1,,,CHEMBL5137039,Eur J Med Chem,2022.0,"{'bei': '14.63', 'le': '0.39', 'lle': '0.67', 'sei': '11.19'}",CHEMBL1532400,,CHEMBL1532400,6.04,0,http://www.openphacts.org/units/Nanomolar,3876136,=,1,1,=,,IC50,nM,,904.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,uM,UO_0000065,,0.904
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24953699,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/BAY-1797', 'standard_type': 'Affinity Phenotypic Cellular Source Knowledge', 'standard_units': None, 'standard_value': None, 'text_value': 'https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/BAY-1797', 'type': 'Affinity Phenotypic Cellular Source Knowledge', 'units': None, 'value': None}]",CHEMBL5210088,Affinity Phenotypic Cellular interaction (Ephys Qpatch Assay in HEK293 cells) EUB0000309b P2RX4,F,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1,,,CHEMBL5169023,,,,CHEMBL4521594,BAY-1797,CHEMBL4521594,6.56,0,http://www.openphacts.org/units/Nanomolar,3897620,=,65,1,=,,IC50,nM,,274.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,274.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24953937,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'https://doi.org/10.1021/acs.jmedchem.9b01304, https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/BAY-1797', 'standard_type': 'Affinity On-target Cellular Source Knowledge', 'standard_units': None, 'standard_value': None, 'text_value': 'https://doi.org/10.1021/acs.jmedchem.9b01304, https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/BAY-1797', 'type': 'Affinity On-target Cellular Source Knowledge', 'units': None, 'value': None}]",CHEMBL5210283,"Affinity On-target Cellular interaction (FLIPR assay (inhibition of ATP-induced calcium influx in HEK293 cells, stably transfected with human P2X4 receptor)) EUB0000309b P2RX4",B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1,,,CHEMBL5169023,,,"{'bei': '16.01', 'le': '0.33', 'lle': '2.72', 'sei': '6.78'}",CHEMBL4521594,BAY-1797,CHEMBL4521594,6.68,0,http://www.openphacts.org/units/Nanomolar,3897780,=,65,1,=,,IC50,nM,,211.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,211.0
,,24953938,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'https://doi.org/10.1021/acs.jmedchem.9b01304, https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/BAY-1797', 'standard_type': 'Affinity On-target Cellular Source Knowledge', 'standard_units': None, 'standard_value': None, 'text_value': 'https://doi.org/10.1021/acs.jmedchem.9b01304, https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/BAY-1797', 'type': 'Affinity On-target Cellular Source Knowledge', 'units': None, 'value': None}]",CHEMBL5210284,"Affinity On-target Cellular interaction (FLIPR assay (inhibition of ATP-induced calcium influx in HEK293 cells, stably transfected with human P2X4 receptor)) EUB0000548a P2RX4",B,,,BAO_0000190,BAO_0000219,cell-based format,NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1,,,CHEMBL5169023,,,,CHEMBL4516843,BAY-207,CHEMBL4516843,,0,http://www.openphacts.org/units/Nanomolar,3897781,>,65,1,>,,IC50,nM,,25000.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,nM,UO_0000065,,25000.0
,,24956677,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'FLIPR assay (inhibition of ATP-induced calcium influx in 1321N1 astrocytoma cells, stably transfected with P2X4 receptor): IC50(human P2X4) = 108 nM, IC50(mouse P2X4) = 112 nM, IC50(rat P2X4) = 233 nM (PMID: 31746599); Patch-clamp experiments (QPatch assay in 1321N1 cells expressing human P2X4): IC50 = 320 nM (PMID: 31746599)', 'standard_type': 'Selectivity Comments', 'standard_units': None, 'standard_value': None, 'text_value': 'FLIPR assay (inhibition of ATP-induced calcium influx in 1321N1 astrocytoma cells, stably transfected with P2X4 receptor): IC50(human P2X4) = 108 nM, IC50(mouse P2X4) = 112 nM, IC50(rat P2X4) = 233 nM (PMID: 31746599); Patch-clamp experiments (QPatch assay in 1321N1 cells expressing human P2X4): IC50 = 320 nM (PMID: 31746599)', 'type': 'Selectivity Comments', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Selectivity number of off-targets', 'standard_units': None, 'standard_value': '0.0', 'text_value': None, 'type': 'Selectivity number of off-targets', 'units': None, 'value': '0.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Selectivity number of targets', 'standard_units': None, 'standard_value': '67.0', 'text_value': None, 'type': 'Selectivity number of targets', 'units': None, 'value': '67.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Screened at 10 µM (in vitro)', 'standard_type': 'Selectivity Remarks', 'standard_units': None, 'standard_value': None, 'text_value': 'Screened at 10 µM (in vitro)', 'type': 'Selectivity Remarks', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'https://doi.org/10.1021/acs.jmedchem.9b01304, https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/BAY-1797', 'standard_type': 'Selectivity Source Knowledge', 'standard_units': None, 'standard_value': None, 'text_value': 'https://doi.org/10.1021/acs.jmedchem.9b01304, https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/BAY-1797', 'type': 'Selectivity Source Knowledge', 'units': None, 'value': None}]",CHEMBL5214543,"Selectivity interaction (Lead profiling screen (Eurofins, GPCRs, ion channels, kinases and transporters)) EUB0000309b P2RX4",B,,,BAO_0000190,BAO_0000357,single protein format,NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1,,,CHEMBL5169023,,,,CHEMBL4521594,BAY-1797,CHEMBL4521594,,0,,3898327,>,65,0,>,,IC50,µM,,30.0,CHEMBL2104,Homo sapiens,P2X purinoceptor 4,9606,,,IC50,µM,,,30.0
